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 ABSTRACT 
 
 Calcium (Ca
2+
)
 
is the most universal and versatile signal in the cell. This versatility 
is based on the speed, amplitude and spatio-temporal patterning of the Ca
2+
 events. The 
inositol 1,4,5-trisphosphate receptor (IP3R) is one of the main Ca
2+
 channels responsible 
for the Ca
2+
 release from the intracellular stores. In a response to various stimuli, IP3R is 
able to generate variety of Ca
2+
 signals, ranging from Ca
2+
 transients to Ca
2+
 oscillations 
of different frequencies.  
In this thesis we studied regulation of canonical and non-canonical signaling 
pathways that activate IP3R-mediated Ca
2+
 signaling. The canonical pathway is 
represented in this thesis by angiotensin II type 1 receptor (AT1R) Gαq/11 protein-coupled 
signaling, which triggers IP3R-mediated Ca
2+
 signals by stimulation of IP3 production.  
The non-canonical pathway is represented by Na,K-ATPase, which activates IP3R 
independently on the presence of IP3 through allosteric effect. 
AT1R, together with dopamine D1-like receptor (D1R), represent a counter-
regulatory system that controls sodium uptake in renal proximal tubules. We have shown 
that AT1R and D1R form a heterodimer. We have demonstrated that the stimulation of 
either of the receptors induce heterologous desensitization of the other receptor. Activation 
of D1R resulted in rapid and reversible uncoupling of AT1R from its G protein-coupled 
signaling pathway followed by internalization of the receptor and vice versa; stimulation 
of AT1R abolished D1R mediated cAMP production and triggered D1R internalization. 
 Na,K-ATPase, in addition to its function as an ion pump, serves also as a signal 
transducer. Ouabain, a highly specific Na,K-ATPase ligand, was shown to trigger slow 
Ca
2+
 oscillations through the Na,K-ATPase/IP3R signaling complex. We have described 
that the cytoskeleton associated protein, ankyrin B, stabilizes the Na,K-ATPase and IP3R 
interaction. Down-regulation of ankyrin B in COS7 cells using siRNA, resulted in 
reduction and dysregulation of ouabain-triggered Ca
2+
 oscillations, and abolishment of 
NF-kB activation. 
 In 2006, Hilgenberg et al. (Cell 2006 Apr 125:359) reported that 20-kD C-terminal 
fragment of agrin (agrin C20) is a new ligand of Na,K-ATPase α3 that inhibits its pumping 
activity. The original purpose of our study was to examine whether agrin C20 has also 
capacity to induce signaling function of Na,K-ATPase α3. We have shown that the 
solubilized agrin C20, which we received from the authors of the Cell paper, is not 
selective for Na,K-ATPase α3, but has a capacity to trigger slow Ca
2+
 oscillations in COS7 
cells via Na,K-ATPase α1 and also to inhibit the pumping activity of the Na,K-ATPase α1. 
These effects were dependent on the intact ouabain binding site. Solubilized agrin C20 was 
also found to trigger slow Ca
2+
 oscillations superimposed on the spontaneous fast 
frequency Ca
2+
 oscillations in rat primary hippocampal neurons. The naturally occurring 
22-kD C-terminal fragment of agrin did not trigger Ca
2+
 signal in COS7 cells. Mass-
spectrometry analysis revealed presence of 5-7 mM ouabain in the solubilized agrin C20 
sample. Ouabain-free agrin C20 was not found to have any effect on the Na,K-ATPase 
activity in the mouse brain lysate. 
 In conclusion we have described new mechanisms regulating canonical and non-
canonical activators of IP3R Ca
2+
 signaling through protein-protein interaction and 
allosteric modulation. 
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1 INTRODUCTION 
 
1.1 Calcium signaling 
 
Calcium (Ca
2+
) has been recognized as a universal second messenger that is 
involved in the variety of vital cellular functions and processes like proliferation, 
fertilization, differentiation, learning and memory, apoptosis, excretion, etc. The 
ability of Ca
2+
 signaling to regulate all these diverse processes is allowed by its high 
versatility, which depends on speed, amplitude and spatial-temporal patterning. 
Rapid highly localized Ca
2+
 spikes regulate fast responses, whereas slower responses 
are controlled by global Ca
2+ 
transients and intracellular Ca
2+
 waves (Berridge et al., 
2003). 
In the resting state the cytosolic Ca
2+
 concentration is low, around 100 nM, 
whereas the extracellular and intracellular stores reach the Ca
2+
 concentration 1000 
to 10 000 times higher (Uhlen and Fritz, 2010). This high gradient makes the cells 
capable to sense even small changes in the cytosolic Ca
2+
 level. 
 Every cell possesses a Ca
2+
 signaling toolkit containing mechanisms that trigger 
Ca
2+
 signal, mechanisms of Ca
2+
 entry into the cytoplasm, and mechanisms that 
restore the resting state of the cytosolic Ca
2+
. The extensive variability of each 
component of the Ca
2+
 signaling and the possibility to assemble various 
combinations enables to create wide spectrum of different spatial and temporal 
profiles of the Ca
2+
 signal. The Ca
2+
 signaling toolkit includes cell surface receptors, 
Ca
2+
 channels, Ca
2+
 pumps and exchangers and Ca
2+
 sensors. 
Ca
2+
 signal can be generated as a release from the intracellular stores as well as 
an influx from extracellular space across the plasma membrane. The main 
intracellular Ca
2+
 store is considered to be an endoplasmic reticulum (ER); however 
other cell compartments such as mitochondria, Golgi apparatus (GA), nuclear 
envelope, endosomes and lysosomes possess high Ca
2+
 concentration as well. 
 
1.2 Ca2+ transport mechanisms 
1.2.1  Plasma membrane 
Ca
2+
 can enter cell from the extracellular space via variety of Ca
2+ 
channels of 
different properties which use the electrochemical gradient across the plasma 
membrane as driving force for Ca
2+
 transport. 
1.2.1.1 Voltage gated calcium channels (VGCCs) 
VGCCs can be found mostly on the plasma membrane of excitable cells. 
They are activated by membrane depolarization and generate rapid Ca
2+
 fluxes that 
control processes such as contraction, secretion, neurotransmission, and gene 
expression. Their activity is essential to couple electrical signals in the cell surface to 
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physiological events in cells. Expression of the VGCCs has been also described on 
the plasma membrane of the non-excitable cells like renal tubular cells (where 
VGCCs play role for example in volume regulatory machinery, or apoptosis) (Bozic 
and Valdivielso, 2012), or T-cells (where VGCCs have been shown to shape the 
TCR Ca
2+
 response) (Badou et al., 2013).   
1.2.1.2 Receptor-operated calcium channels  
Receptor-operated Ca
2+
 channels are opened upon binding of their specific 
ligand. Typical example of the plasma membrane receptor operated Ca
2+
 channel is 
NMDA receptor that is activated by glutamate. NMDA receptor is not selective for 
Ca
2+
 but it is also permeable for Na
+
 and K
+
. NMDA receptor is localized to the 
postsynaptic density and it is responsible for most of the Ca
2+
 influx in a response to 
the synaptic activity. NMDAR Ca
2+
 signal is crucial for induction of synaptic 
plasticity and for activating intracellular signaling pathways involved in learning and 
memory (Paoletti et al., 2013). 
1.2.1.3 Store-operated calcium channels (SOCs) 
SOCs are Ca
2+
 channels in the plasma membrane that are activated by 
depletion of the ER intracellular Ca
2+
 stores. SOCs are composed of the protein 
complex including plasma membrane protein Orai1 that forms a pore of the Ca
2+
 
channel and STIM1 proteins that are located in the membrane of ER and can sense 
decrease of the luminal Ca
2+
 level. When the ER Ca
2+
 stores are depleted, STIM 
associates with Orai in the plasma membrane and activates store-operated Ca
2+
 entry 
and replenishing of ER Ca
2+
 stores (Berna-Erro et al., 2012). 
 
 
 
 
Fig 1.1 Ca
2+
 transporters 
 
1.2.1.4 Na+/Ca2+ exchanger (NCX) 
NCX is an ion transport channel that transports Ca
2+
 across the plasma 
membrane against its electrochemical gradient utilizing energy stored in the 
VGCC
SOC TRPC
NCX
PMCA
IP3R
RyR
SERCA
Ca2+
Ca2+
Ca2+
ER
CYTOSOL
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electrochemical gradient of Na
+
 (mainly maintained by Na, K-ATPase). Typically it 
transports one Ca
2+
 in exchange for three Na
+
. It is a reversible transporter and the 
direction of the Ca
2+
 transport depends on the Na
+
, Ca
2+
, and K
+
 concentrations, 
membrane potential and the transport stoichiometry. In non-excitable cells it is one 
of the main mechanisms that extrude Ca
2+
 from the cell. In the conditions when 
intracellular Na
+
 raises (for example after Na, K-ATPase inhibition) the NCX may 
work in forward direction and let Ca
2+
 flow in (Ruknudin and Lakatta, 2007). 
1.2.1.5 Plasma membrane Ca2+ ATPase (PMCA) 
PMCA is a transport protein that removes Ca
2+
 from the cell. To move Ca
2+ 
ions across the plasma membrane against their electrochemical gradient it uses 
energy from the ATP hydrolysis. PMCA together with NCX are the main 
mechanisms of Ca
2+
 extrusion. Since there exists a great electrochemical gradient 
that forces entry of the Ca
2+ 
into the cell, it is extremely important to keep the 
cytosolic Ca
2+ 
levels low for proper cell signaling as well as to prevent Ca
2+
 induced 
cytotoxicity (Giacomello et al., 2013). 
1.2.1.6 Transient receptor potential channels (TRPCs) 
TRPCs are group of ion channels conducting Ca
2+
, Na
+
, or K
+
, that are in the 
front line of the sensory systems, responding to the signals from the outer 
environment such as temperature, sound, touch, chemicals or light. Most of the 
TRPCs are not Ca
2+
 selective except TRPM4 and 5. Some of the TRPCs family 
members have been shown to be activated after Ca
2+
 depletion of the ER and 
contribute to the store-operated Ca
2+
 entry (Gees et al., 2012). 
1.2.2 Endoplasmic reticulum 
ER is the main store of the intracellular Ca
2+
. Membrane of the ER contains a 
number of proteins, Ca
2+
 channels and pumps that regulate both Ca
2+
 release and 
Ca
2+
 re-uptake.  
1.2.2.1 Inositol 1,4,5-trisphosphate receptor (IP3R) 
IP3R is together with ryanodine receptor the major mechanism of the Ca
2+
 
release from the ER. IP3R is a ligand gated Ca
2+
 channel belonging to a super family 
of ion channels with six transmembrane domains. IP3R mediated Ca
2+
 release is 
essential step in numerous signaling pathways of many vital cell function. IP3R 
function can be regulated by high variety of mechanisms. This assures high 
versatility of the Ca
2+
 signal generated by IP3R and its integration with multiple 
signaling pathways. 
 
Classically, IP3R is divided into three regions. N-terminal ligand binding 
region, regulatory and coupling region, and the C-terminal consisting of six 
transmembrane helices and short cytoplasmic tail. More recently the structure of 
IP3R was divided into five functional domains (Fig 1.2). The IP3 binding core 
domain is the minimum region necessary for recognition and binding of the IP3. N-
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terminal coupling domain physically interacts with IP3 binding domain and functions 
as a suppressor of IP3 binding. Deletion of this region leads to the massive 
enhancement of IP3 binding. The signal for IP3 binding is transferred via N-terminal 
and internal coupling domain to the gatekeeper domain which triggers 
conformational changes in the transmembrane/channel-forming domain that leads to 
opening of the channel (Mikoshiba, 2007). 
 
 
 
Fig 1.2 IP3R structure 
 
Up to date there have been described three subtypes of IP3R encoded by three 
genes: IP3R type1, type2, and type3. Diversity of IP3Rs is further increased by 
existence of splicing variants. Functional IP3R Ca
2+
 channel is formed by four IP3R 
molecules and there has been described both homo- and hetero-tetramers formation. 
IP3R isoforms shares more than 65% homology in their sequence and differs in IP3 
sensitivity, susceptibility to various regulatory mechanisms, and spatial and temporal 
distribution. Most of the cell types express more than one IP3R isoform but their 
expression patterns differ between cell types and tissues (Parys and De Smedt, 2012). 
 
The IP3R function is regulated by a number of factors: 
IP3: IP3 is a ligand and activator of IP3R. IP3 is a second messenger that is produced 
after stimulation of cell surface receptors by various signal molecules like hormones, 
growth factors, neurotransmitters, etc. Precursor of IP3, phosphatidylinositol 4,5- 
bisphosphate, phospholipid present in the plasma membrane can be cleaved by 
phospholipase C (PLC) into IP3 and 1,2-diacylglycerol (DAG), an activator of 
several effectors including protein kinase C (PKC). There have been described six 
families of PLCs and each of them consists of several isoforms and splicing variants. 
This assures the controlled production of IP3 and DAG in different cells type 
triggered by different stimuli and receptors (Vines, 2012). 
Ca
2+
: The IP3R function is regulated by Ca
2+
. The IP3R has bell shaped Ca
2+
 
dependence. Low concentrations of Ca
2+
 (100-300 nM) have stimulatory effect on 
the opening of IP3R channel whereas higher Ca
2+
 concentrations lead to the closing 
of the channel. In the absence of Ca
2+
, IP3 is not able to trigger Ca
2+
 release from ER. 
SUPRESSOR
DOMAIN
IP3 BINDING 
CORE DOMAIN
INTERNAL COUPLING DOMAIN
TRANSMEMBRANE/
CHANNEL-FORMING
DOMAIN
GATEKEEPER
DOMAIN
1 225 579 2275 2590 2749 aa
CYTOSOL CYTOSOLER MEMBRANE
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Binding of Ca
2+
 also increases sensitivity of IP3R to IP3 (Patterson et al., 2004). 
There have been described seven sites for Ca
2+
 binding. Ca
2+
 has been also suggested 
to play a role in triggering IP3R ubiquitination (Alzayady and Wojcikiewicz, 2005). 
Beside the regulation of IP3R function by direct binding of Ca
2+
 there has been 
proposed an indirect effect through Ca
2+
 binding proteins like calmoduline. IP3R is 
not only sensitive to the Ca
2+
 concentration in the cytoplasm but is also regulated by 
the concentration in the lumen of the ER. The low Ca
2+
 concentration in the ER lead 
to IP3R inhibition to avoid excessive Ca
2+
 depletion of the ER (Caroppo et al., 2003). 
Phosphorylation: IP3R is phosphorylated by multiple kinases. Phosphorylation of 
IP3R by c-AMP dependent kinase (PKA) increases its responsiveness to IP3. This is 
particularly interesting because it provides the cross-talk between signaling of two 
main second messengers, cAMP and Ca
2+
. The state of PKA phosphorylation can be 
very dynamically changed since IP3R is in the complex with both PKA and protein 
phosphatase 1 and 2A. cGMP dependent kinase (PKG) phosphorylates IP3R at the 
same sites as PKA. Ca
2+
 activated protein kinase C (PKC) and Ca
2+
/calmoduline 
protein kinase II (CAMK-II) phosphorylation of IP3R increases its sensitivity to IP3- 
mediated Ca
2+
 release and thus provides positive feedback loop. IP3R can be further 
phosphorylated by the tyrosine kinases from Src family, various serine/threonine 
kinases, cell cycle- dependent kinases, and others (Patterson et al., 2004). 
Protein-protein interaction: To date there have been identified up to 50 proteins that 
can interact with IP3R and regulate its localization and function. Together with 
previously described regulatory mechanisms, interaction with various proteins 
contributes to an accurate and precise control of IP3R signaling in response to 
different extracellular stimuli. One group of IP3R interacting proteins are the 
cytoskeleton associated proteins and scaffolding proteins which promote stable 
subcellular localization of IP3R. One example are the ankyrins, a family of adaptor 
proteins that can interact both with proteins in the membrane of ER and the plasma 
membrane and thus can help to form microdomains between the two membranes 
(Mohler et al., 2005). In neuronal cells, another scaffolding protein, Homer, 
assembles IP3R with mGluR and provides regulation of the mGluR/ IP3R signaling at 
the excitatory synapse (Tu et al., 1998). Since increased cytosolic Ca
2+
 level leads to 
cell death by apoptosis, it is not surprising that the IP3R is in complex with many 
apoptotic proteins. During apoptosis, IP3R can be cleaved by apoptotic proteases 
caspase 3 and calpain. Soon after cell receives apoptotic stimuli, cytochrome c is 
translocated to the proximity of ER, where it interacts with C-terminus of IP3R and 
inhibits Ca
2+
-induced closing of the IP3R. Subsequent increase of the cytosolic Ca
2+ 
concentration causes release of more cytochrome c (Boehning et al., 2003). Recently 
there has been described another IP3R binding protein, called IRBIT, which serves as 
the IP3R pseudo-ligand. It binds to the IP3 binding site of IP3R. In low IP3 
concentration, IRBIT binds to the IP3R and decreases its sensitivity to IP3, while in 
high IP3 concentrations IRBIT is released and IP3R can be activated (Ando et al., 
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2006; Ando et al., 2003). Study by Zhang et al. (2006) has shown that N-terminus of 
the IP3R can directly interact with N-terminus of Na,K-ATPase, and that ouabain, 
Na,K-ATPase ligand, triggers conformational changes that lead to IP3R activation 
independently on the presence of IP3.  
 
1.2.2.2 Ryanodine receptor (RyR) 
Ryanodine receptors are localized in the plasma membrane of sarco-
/endoplasmic reticulum (SR/ER). They are known mostly for their involvement in 
excitation-contraction coupling, releasing of Ca
2+
 from the sarcoplasmic reticulum 
and thus driving muscle contraction. The activation of RyR is controlled by the 
concentration of the cytosolic Ca
2+
. Small elevation of intracellular Ca
2+
 induces 
opening of RyR and release of more Ca
2+
. RyRs are mainly responsible for Ca
2+
-
induced Ca
2+
 release (CICR) which is crucial for excitation-contraction coupling in 
cardiac muscle (Fabiato, 1983) as well as it is important mechanism of Ca
2+
 
signaling in many cells. The high intracellular Ca
2+
 concentration on the other hand 
causes closing of RyR channels. RyRs are also capable of sensing the Ca
2+
 
concentration inside the SR/ER. In the condition when SR/ER is overloaded, RyR 
opens and releases Ca
2+
 into the cytosol. This process is called store overload-
induced Ca
2+
 release (SOICR) (Palade et al., 1983). RyR opening is not entirely 
dependent on the presence of Ca
2+
. The skeletal muscle isoform of RyR is believed 
to interact with dihydropyridine receptor and to be allosterically activated after the 
voltage changes across the plasma membrane even in the absence of the extracellular 
Ca
2+ 
(Proenza et al., 2002). RyRs function can be modulated by protein-protein 
interactions (e.g. with calmoduline, homer), and phosphorylation (e.g. PKA, PKG, 
CaMK II) (Ozawa, 2010).  
1.2.2.3 Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) 
SERCA is a transporter that actively translocates Ca
2+
 from the cytosol to the 
internal stores of SR/ER. SERCA plays major role in the muscle contraction and its 
dysfunction is connected with many pathophysiological conditions, such as heart 
failure (Frank et al., 2002). Overall, the Ca
2+
 homeostasis that SERCA pump 
contributes to is important for Ca
2+
 signaling. Nevertheless, more regulated function 
of SERCA has been implicated in specific Ca
2+
 signaling events such as generation 
and propagation of Ca
2+
 waves (Li et al., 2012; Maxwell and Blatter, 2012). 
 
1.3 Ca2+ oscillations 
Ca
2+
 signal is a result of the interplay between activation and inactivation of 
Ca
2+
 channels that transport Ca
2+ 
from extracellular space as well as from internal 
stores. It is well known that a robust and prolonged increase of the cytosolic Ca
2+
 
level leads to cell death both by apoptosis and necrosis. By utilizing brief pulses of 
Ca
2+
, instead of tonic rises, cells avoid the deleterious effects of sustained cytosolic 
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Ca
2+
 levels. Furthermore, signaling with Ca
2+ 
oscillations is beneficial for the cell 
since the combination of the duration, amplitude and frequency of the Ca
2+
 peaks can 
hypothetically give rise to an infinite number of signals. 
With the development of methods enabling to detect Ca
2+
 levels in the living 
cells, Ca
2+
 oscillations have been shown to regulate numerous physiological 
processes through the life, including fertilization, cell maturation and differentiation, 
cell cycle progression, mitochondrial respiration, chemotaxis, secretion and gene 
transcription (Thul et al., 2008).  
 
1.3.1 Generation of cytosolic Ca2+ oscillations 
It is generally accepted that Ca
2+
 oscillations are generated as a periodical 
release of the Ca
2+
 from the internal stores through the IP3R. In excitable cells the 
initial Ca
2+
 entry might be due to an activation of the plasma membrane channels, 
followed by the amplification of the signal by release from the internal stores. 
The enormous complexity of the Ca
2+
 signaling makes it difficult to fully 
understand the mechanism behind the generation of Ca
2+
 oscillations. Data resulting 
from more than 20 years of extensive studies together with mathematical modeling 
proposed a model based on the biphasic regulation of IP3R and phenomena of Ca
2+
 
induced Ca
2+
 release (CICR). 
In simplification, when the intracellular Ca
2+
 level increases, in most cases 
due to IP3 induced IP3R activation, IP3R is sensitized by the Ca
2+
 which leads to 
amplification of the initial signal and further increase of the cytosolic Ca
2+
 level. 
However the high Ca
2+
 level has a negative feedback on the IP3R, which closes 
allowing Ca
2+
 level to decrease (Fig 1.3). In this model, Ca
2+
 oscillations can be 
generated under the constant concentrations of IP3 (Dupont et al., 2011).  
 
 
 
Fig 1.3 Ca
2+
 induced Ca
2+
 release 
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Although this model is applicable to most of the IP3 stimulated Ca
2+
 
oscillations, it can´t be considered to be universal. Experimental data have shown 
that in some systems IP3R generated Ca
2+
 oscillations can´t be explained by CICR. 
For example in MDCK cells (Hirose et al., 1999) and Chinese hamster ovary cells 
(Young et al., 2003) each Ca
2+
 peak follows elevation of IP3. In this model, cross-
talk between second messengers IP3 and Ca
2+
 plays a crucial role for a generation of 
the Ca
2+
 oscillations. IP3 induced Ca
2+
 release increases sensitivity of IP3R for IP3. 
Furthermore, Ca
2+
 has been shown to be able to activate some of the PLC isoforms, 
which leads to production of more IP3. Another model of Ca
2+
 oscillations that are 
not dependent on CICR are the oscillations induced by activation of mGluR5. 
mGluR5 is believed to undergo a rapid cycle of PKC phosphorylation  and 
dephosphorylation mediated desensitization and resensitization (Kim et al., 2005; 
Nash et al., 2001).   
1.3.2 Regulation of Ca2+ oscillations pattern 
The pattern of Ca
2+
 oscillations is dependent on the timing of the Ca
2+
 
channel opening, Ca
2+
 clearance, and Ca
2+
 stores reloading. It can be regulated on 
different levels and each component of the signaling machinery contributes to the 
shaping of the Ca
2+
 response. 
1.3.2.1 Agonist concentration control of Ca2+ oscillations 
Ca
2+
 oscillations are triggered by the physiological range of agonist 
concentration, while saturating concentrations often lead to a single and broad Ca
2+
 
transient. Increase of the agonist concentrations within the physiological range often 
result in increase of Ca
2+
 oscillation frequency (Berridge, 1993; Woods et al., 1986). 
1.3.2.2 The role of IP3R in the regulation of Ca
2+
 oscillations 
Regulation of the IP3R properties, such as IP3 or Ca
2+
 affinity, has an effect on 
the Ca
2+
 signaling pattern.  IP3R isoforms differs in their affinity for IP3 and Ca
2+
 and 
it has been shown that activation of specific IP3R subtypes results in generation of 
Ca
2+
 signaling with different characteristics. Miyakawa et al. (1999) has shown that 
in genetically modified B-cells expressing either one of the IP3R isoforms or their 
combination, the most IP3 sensitive IP3R type 2 generates robust and highly regular 
Ca
2+
 oscillations, IP3R type 1 generates less regular Ca
2+
 oscillations, and IP3R type 
3, which is the least IP3 and Ca
2+
 sensitive gives rise only to a Ca
2+
 transient. In 
vascular myocytes expressing IP3R1 and IP3R2, acetylcholine fails to induce Ca
2+ 
oscillations when IP3R2 function is compromised (Morel et al., 2003). Hattori et al. 
(2004) has shown that wild type HeLa and COS7 cells, that express both IP3R1 and 
IP3R3, respond to ATP stimulation with robust Ca
2+
 transient, while downregulation 
of IP3R3 isoform using siRNA leads to oscillatory response to the same stimuli. This 
suggests that IP3R3 has in anti- Ca
2+
 oscillatory function in these cells. 
Phosphorylation of the IP3R in most cases changes its affinity for IP3 and Ca
2+
 
and therefore, it may play role in shaping of the Ca
2+
 oscillations. LeBeau et al. 
(1999) demonstrated that the phosphorylation of IP3R in the pancreatic acinar cells 
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determines the properties of IP3R generated Ca
2+
 oscillations. While acetylcholine or 
carbachol induce high frequency oscillations superimposed on elevated basal level of 
Ca
2+
, cholecystokinin triggers slow baseline Ca
2+
 spikes. Both stimuli induce 
activation of PLC and release of Ca
2+
 through IP3R, but only cholecystokinin induces 
rapid phosphorylation of the IP3R. Lee et al. (2006) has shown that inhibition of 
MAPK/ERK2 mediated phosphorylation of IP3R1 lead to inability of the IP3R to 
generate Ca
2+
 oscillations during mouse oocyte maturation. In DT-40 lymphoma B-
cells phosphorylation of the IP3R1 by PKA decreases threshold for induction of Ca
2+
 
oscillations (Wagner et al., 2004). The role of CaMKII activity in histamine induced 
Ca
2+
 oscillations in HeLa cells were demonstrated as the treatment with CaMKII 
specific inhibitor during oscillations caused one large Ca
2+
 spike before the 
oscillations were terminated (Zhu et al., 1996).  
As mentioned earlier, IP3R can interact with number of proteins. These 
interactions often contribute to shape the IP3R generated Ca
2+
 signal. IP3R has been 
shown to interact with the Bcl-2 family of anti-apoptotic proteins. There have been 
reported bi-directional regulation of the IP3R generated Ca
2+
 signaling by Bcl-2. In 
T-cell cell line, strong activation of TCR receptor leads to massive increase of 
intracellular Ca
2+
 that is inhibited in the presence of Bcl-2. On the other hand, when 
the TCR receptor is activated in the moderate level, it triggers Ca
2+
 oscillations; 
which´s frequency and duration are promoted by the expression of Bcl-2 (Zhong et 
al., 2006). In MCF-7 cells, Ca
2+
 transient rather than Ca
2+
 oscillations was triggered 
by ATP in the cells overexpressing Bcl-2 (Palmer et al., 2004). IRBIT has been 
described as an IP3R pseudoligand that decreases IP3R sensitivity to IP3. Depletion of 
IRBIT by siRNA in HeLa cells increased the number of HeLa cells responding to 
ATP treatment with Ca
2+
 oscillations (Ando et al., 2006). Mutations in presenilins 
are associated with development of the Alzheimer´s disease. Presenilins interact with 
IP3R and the expression of Alzheimer associated presenilin mutants in DT-40 cells 
resulted in an increase of frequency of Ca
2+
 oscillations triggered by α-IgM (Cheung 
et al., 2008). 
1.3.2.3 The role of GPCRs in the regulation of Ca2+ oscillations 
One of the most common triggers that stimulates PLC activity and IP3 
production is through activation of G protein-coupled receptors (GPCRs). Many 
studies have reported the role of regulation of the GPCR function in the Ca
2+
 
oscillation pattern formation. One of the mechanisms that regulate frequency of Ca
2+
 
oscillations is controlled by the activity of regulators of G protein signaling proteins 
(RGS) that are responsible for inactivation of the G protein by GTP hydrolysis. Luo 
et al. (2001) have demonstrated that disruption of the RGS activity resulted in two- 
times increase of frequency of cholecystokinin (CCK)-induced Ca
2+
 oscillations 
compare to control (Shin et al., 2003). The mGluR5 triggered Ca
2+
 signaling has 
been shown to be modified by Norbin, factor involved in long-term potentiation 
(LTP), synaptic plasticity, learning and memory. Activation of mGluR5 transfected 
into HEK293 cells induced Ca
2+
 oscillations that assigned longer duration and higher 
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number of peaks in the presence of Norbin. Authors have shown that deletion of 
Norbin leads to decrease of the amount of mGluR5 in the plasma membrane (Wang 
et al., 2009).  
1.3.2.4 Ryanodine receptors (RyRs) 
Another way of Ca
2+
 release from internal stores is through ryanodine 
receptors. RyRs are activated by Ca
2+
 and thus they significantly contribute to the 
CICR. The RyR function is most studied in the sarcoplasmic reticulum of muscle 
cells, where it cooperates with the IP3R to generate Ca
2+
 oscillatory signal. 
 
1.4 Decoding of Ca2+ signal 
Ca
2+
 activates a number of Ca
2+
 binding proteins that either trigger downstream 
effects or take part on the positive/negative feedback of the Ca
2+
 signaling machinery 
itself. Ca
2+
 can bind directly to an effector molecule that is responsible for the 
biological effect of the Ca
2+
 signal (like troponins responsible for muscle 
contraction) or it can activate other signaling molecules. In general, decoding of the 
Ca
2+
 signal depends on the kinetics of the Ca
2+
 binding and dissociation and the 
dynamics and timing of the activation and inactivation of the target molecule. 
The key players responsible for Ca
2+
 oscillations frequency decoding are 
calmodulin (CaM) and protein kinase C (PKC). CaM is a promiscuous regulator with 
several hundreds of targets known to date, including kinases, phosphatases, 
cytoskeletal proteins, synaptic proteins, cell cycle proteins, ion channels, and the 
buffer proteins that regulate intracellular Ca
2+
 stores. Each CaM molecule possesses 
four Ca
2+
 binding sites that differ in Ca
2+ 
binding affinity and kinetics. Moreover 
Ca
2+
 needs to compete with Mg
2+
 for CaM binding. Binding of Ca
2+
 results in 
conformational changes of CaM and binding to target molecule.  
One of the most widely studied CaM target is the family of Ca
2+
/calmodulin-
dependent kinases (CaMK). The most common CaMKII can be activated by high 
frequency (in a range of Hz) Ca
2+
 spikes. CaMKII is an octamer or decamer and each 
of the subunit is independently regulated by Ca
2+
-bound CaM. One single Ca
2+
 peak 
is not enough to fully activate the kinase. Instead cumulative activation during 
repetitive Ca
2+
 elevations leads to the kinase activation. If the time between two Ca
2+
 
peaks is longer than a time needed for CaM dissociation, CaMKII activity remains 
low (De Koninck and Schulman, 1998; Dupont et al., 2003). Calcineurin is a 
Ca
2+
/CaM activated serine/threonine phosphatase that beside many other targets 
dephosphorylate CaMKII and thus decreases its activity. Unlike CaMKII, calcineurin 
is optimally activated by Ca
2+
 oscillations of frequency around 10 m Hz. The 
properties of calcineurin allow it to be activated with the high Ca
2+
 oscillations 
frequency as well. However, calcineurin is competing with CaMKII for active CaM 
binding and at higher frequencies, the activation is shifted towards CaMKII (Li et al., 
2012). 
Conventional protein kinase C (PKC) is activated by binding of Ca
2+
 and 
DAG. Upon Ca
2+
 stimulation, PKC is translocated to the proximity of the plasma 
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membrane, where it interacts with DAG and is fully activated. The low frequency of 
the Ca
2+
 oscillations leads to the fluctuations of the PKC activity, which always 
returns to the basal level between two Ca
2+
 peaks. On the other hand higher 
frequencies or persistent Ca
2+
 increase lead to higher and stable amplitude of the 
PKC activity (Oancea and Meyer, 1998). 
Ca
2+
 oscillation frequency has been shown to dictate which of the Ca
2+
 
dependent transcription factors NF-AT (Dolmetsch et al., 1998; Li et al., 1998), NF-
κB (Dolmetsch et al., 1998), and Oct/OAP (Dolmetsch et al., 1998) will be activated. 
While high frequencies are able to efficiently activate function of all three 
transcription factors, when the periodicity of Ca
2+
 spikes declines to less than 400s 
only NF-κB is activated (Dolmetsch et al., 1998).  The difference in the frequency 
requirements among these factors lies in their stability in the nucleus. NF-κB has 
been shown to persist in the nucleus up till 16 min, while NF-AT is rapidly 
rephosphorylated and exits the nucleus (Dolmetsch et al., 1997). 
MAPK/ERK signaling cascade is activated by many stimuli and integrates 
different signaling pathways. Ca
2+
 oscillations frequency has been shown to 
modulate activity of Ras protein, an upstream component of the MAPK/ERK 
pathway. It has been shown that Ras is more efficiently stimulated by Ca
2+
 
oscillations than by sustained Ca
2+
 increase (Kupzig et al., 2005). Guanine nucleotide 
exchange factors (GRFs) and RasGTPase activating proteins (RasGAPs), the main 
regulators of Ras activity, have been shown to be regulated by direct binding of the 
Ca
2+
 (Feig, 2011; Walker et al., 2004). 
 
 
1.5 Na,K-ATPase 
 
Na,K-ATPase is an integral plasma membrane enzyme expressed in virtually 
every cell. Its main function is to maintain high gradient of Na
+
 and K
+
 across the 
plasma membrane. It is a main determinant of intracellular Na
+
 concentration. It uses 
energy from the ATP hydrolysis to transport 3 Na
+
 out and 2 K
+
 in the cell (Fig 1.4). 
Due to this 3 Na
+
/2 K
+
 stoichiometry the transport is electrogenic, thereby generating 
electric potential difference across the plasma membrane. The energy saved in the 
electrochemical gradient of Na
+
 is used by many symport and antiport transporters 
such as Na
+
/Ca
2+
-exchanger, Na
+
/H
+
-exchanger, Na
+
/K
+
/2Cl, Na
+
/glucose, 
Na
+
/amino acids co-transporters. This way Na
+
 controls directly or indirectly many 
essential cell functions like transport of various compounds, regulation of cell 
volume, intracellular pH, and cytosolic Ca
2+
 concentration. The turnover of the 
Na,K-ATPase is responsible for approximately 30% of the total oxygen consumption 
and in some organs such as brain and kidney more than 50% of the energy released is 
used for the active Na
+
/K
+
 transport (Clausen et al., 1991).  
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Fig 1.4 Na,K-ATPase ion transport 
 
1.5.1 Na,K-ATPase structure 
Na,K-ATPase is composed of three subunits in equimolar ratios. The catalytic 
α subunit together with the β subunit forms functional enzyme regulated by third 
subunit that belongs to the FXYD protein family.  
The catalytic α subunit is a large polypeptide (≈110 kD) consisting of ten 
transmembrane domains, cytosolic N- and C-termini and four cytoplasmic loops. The 
α subunit is responsible for the ion transport activity. It contains ATP binding site, 
Na
+
 and K
+
 binding sites, regulatory phosphorylation sites and binding sites for 
cardiac glycosides (Lingrel and Kuntzweiler, 1994). 
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Fig 1.5 Structure of the Na,K-ATPase 
 
 
The β subunit is an accessory subunit which is important for the maturation and 
transport of the enzyme to the plasma membrane (Geering, 1991) and is involved in 
the occlusion of K
+
 and the modulation of the K
+
 and Na
+
 affinity of the enzyme 
(Geering, 2001; Lutsenko and Kaplan, 1993). It crosses plasma membrane only once 
and the small N-terminal end is located into the cytoplasm, while long C-terminus is 
extracellular. Last regulatory subunit represented by FXYD proteins is not essential 
for Na,K-ATPase catalytic function. It spans plasma membrane once having short 
intracellular C-terminus and extracellular N-terminus. They have a regulatory 
function modulating kinetics of the Na
+
 and K
+
 transport (Garty and Karlish, 2006; 
Therien and Blostein, 2000). Crystal structure of the Na,K-ATPase heterotrimer has 
been recently resolved (Kanai et al., 2013; Morth et al., 2007; Nyblom et al., 2013; 
Shinoda et al., 2009). 
Four isoforms of the α subunit, α1, α2, α3, and α4; three isoforms of the β 
subunit, β1, β2, and β3; and 7 FXYD proteins have been identified in mammals. 
(Geering, 2006). Alpha isoforms are expressed in a tissue-specific and 
developmentally regulated manner. The α1 is expressed ubiquitously. High levels of 
the α2 isoform expression can be found in skeletal muscle, heart, glia cells, 
adipocytes, vascular smooth muscle, and eye. The α3 isoform is neuron specific but 
can be also found in ovaries, embryonic cardiomyocytes, and white blood cells of 
some species. The α4 isoform is expressed in sperms, where it is required for sperm 
motility (Lingrel, 2010; Orlowski and Lingrel, 1988; Woo et al., 2002). Alpha 
isoforms differ in their kinetics and substrate affinities (Dobretsov and Stimers, 
2005; Munzer et al., 1994). 
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1.5.2 The catalytic cycle of Na,K-ATPase 
During the catalytic cycle of the Na,K-ATPase three Na
+
 ions are transported 
out of the cell and two K
+
 ions are countertransported out. The Post-Alberts model 
describes the enzymatic kinetics of Na,K-ATPase (Albers, 1967; Post et al., 1972). 
There are two major conformational states of Na,K-ATPase, E1 and E2. The pump 
with bound ATP binds three intracellular Na
+
 ions (E1-ATP 3Na
+
). ATP is 
hydrolyzed leading to the phosphorylation of the pump (E1P-ADP 3Na
+
).  Release of 
ADP and one Na
+
 ion leads to conformational change of the pump towards E2P state 
(E2P 2Na
+
), release of the two remaining Na
+
 and binding of two extracellular K
+
 
(E2P 2K
+
). Binding of K
+
 leads to dephosphorylation of the pump (E2-2K
+
). 
Dissociation of the liberated phosphate and ATP binding (E2-ATP 2K
+
) stimulates 
K
+
 release and changing the enzyme conformation from E2 to the E1 state. 
 
Fig 1.6 Simplified Post-Albers model for ion transport by Na,K-ATPase 
 
Analysis of the crystal structure of Na,K-ATPase in different states helped to 
understand the mechanisms of ion transport through the plasma membrane. Ion 
binding sites and ion pathways have been described (Kanai et al., 2013; Morth et al., 
2007; Nyblom et al., 2013; Ogawa et al., 2009). The identification of the critical 
amino acid residues for the catalytic function of Na,K-ATPase helps to explain or 
predict the functional consequences of the Na,K-ATPase disease-related mutations.  
1.5.3 Regulation of the Na,K-ATPase function 
The role of the Na,K-ATPase as a determinant of the electrochemical gradient 
across the plasma membrane is pivotal for the cell survival. Cell is a very dynamic 
system, therefore Na,K-ATPase activity has to be controlled in a precise way in 
response to the changes of the ionic environment. Na,K-ATPase activity is regulated 
by a number of mechanisms. 
1.5.3.1 Substrate concentration 
The most straightforward mechanism of the Na,K-ATPase activity regulation 
is  through substrate availability and concentration. Na,K-ATPase is activated by Na
+
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and ATP in the cytosolic side and K
+
 in the extracellular space. Since the cytosolic 
concentration of Na
+
 is under normal conditions low, even a small change in the 
intracellular Na
+
 level has significant effect on Na,K-ATPase activity (Therien and 
Blostein, 2000).  
1.5.3.2 Phosphorylation 
Activity of the Na,K-ATPase is regulated by a number of hormones such as 
dopamine (Aperia et al., 1987), parathyroid hormone (Ribeiro et al., 1994), prolactin 
(Ibarra et al., 2005), angiotensin II (Gutman et al., 1972), epinephrine, norepinephrin 
(Aperia et al., 1992), or insulin (Gavryck et al., 1975). The main mechanism of 
hormone control of the Na,K-ATPase activity is through its phosphorylation and 
dephosphorylation. Na,K-ATPase contains phosphorylation sites for PKA and PKC 
kinases (Therien and Blostein, 2000). PKC site is localized to the N-terminus of the 
α1 subunit (Beguin et al., 1994). PKA phosphorylation site is located in the last 
cytoplasmic loop of α subunit and is conserved among all isoforms (Cheng et al., 
1997; Fisone et al., 1994). Cheng et al. (1999) have demonstrated that the 
intracellular Ca
2+
 concentration is important determinant of the effect of PKA and 
PKC phosphorylation on the Na,K-ATPase activity. Dynamic simulation based on 
the crystal structure of the Na,K-ATPase revealed that the PKA phosphorylation site 
can modulate pumping activity by changing the accessibility of the ion-binding site 
(Poulsen et al., 2012). Na,K-ATPase is dephosphorylated by phosphatases like PP1, 
PP2B, or calcineurin (Therien and Blostein, 2000). The phosphorylation and 
dephosphorylation represent short-term regulation mechanism of Na,K-ATPase 
activity. Hormones such as corticosteroids (Verrey et al., 1996) or thyroid hormone 
(Cheng et al., 2010) control long term regulation of Na,K-ATPase by affecting its 
synthesis and degradation. 
1.5.3.3 Plasma membrane lipid composition 
The lipid composition of the plasma membrane has been suggested to modulate 
the Na,K-ATPase activity. Crystal structure of the Na,K-ATPase showed binding of 
a cholesterol molecule (Morth et al., 2007) and the level of cholesterol in the plasma 
membrane has been shown to have effect on the Na,K-ATPase activity (Cornelius, 
1995; Cornelius et al., 2001).  
1.5.3.4 Association with cytoskeletal proteins 
Association of Na,K-ATPase with cytoskeletal proteins regulate trafficking and 
subcellular localization of Na,K-ATPase and thus indirectly affect its activity 
(Devarajan et al., 1994). Na,K-ATPase activity has been also shown to be affected 
directly by interaction with ankyrin and adducin (Ferrandi et al., 1999). Ankyrins are 
a family of adaptor proteins responsible for the localization of membrane and 
cytosolic proteins into specialized membrane domains. Vertebrate ankyrins fall into 
three classes: ankyrins-R (Ank-R), ankyrins-B (Ank-B), and ankyrins-G (Ank-G) 
(Mohler et al., 2002). Ank-B has been shown to tether Na,K-ATPase, NCX, and IP3 
receptor into microdomains localized in the T-tubules of cardiomyocytes (Mohler et 
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al., 2005). Mutations in Ank-B lead to cardiac arrhythmia and long-QT syndrome 
(Mohler et al., 2003). Ank-G has been also shown to interact with Na,K-ATPase and 
to regulate its trafficking from ER to Golgi apparatus in polarized cells (Stabach et 
al., 2008). 
1.5.3.5 Ligands of Na,K-ATPase 
Na,K-ATPase activity is dose dependently inhibited by its specific ligands, 
cardiotonic steroids (CTS). To the CTS family belongs for example plant derived 
digitalis which is used for centuries as a cardiac stimulant. In the venom of toads 
structurally related bufadienolides have been found. Another digitalis-like 
compound, widely used in the research, is ouabain.  Endogenous ouabain (Hamlyn et 
al., 1991) and bufadienolides (Hilton et al., 1996) have been identified in human 
body. Recently a crystal structure of ouabain/Na,K-ATPase  complex has been 
resolved (Laursen et al., 2013; Ogawa et al., 2009). The affinity of the Na,K-ATPase 
α subunit to CTS differs between isoforms and species. While for example primates 
express all α isoforms with high ouabain sensitivity, in rodents the ubiquitous α1 
isoform is about 1000 times less ouabain sensitive compare to α2 and α3 isoforms 
(O'Brien et al., 1994). 
In 2006, Hilgenberg et al. reported that Na,K-ATPase α3 is a neuron specific 
ligand for agrin. Agrin is a proteoglycan abundantly expressed in neuromuscular 
junctions where it induces acethlycholine receptor clustering via signaling through 
MuSK/LRP4 receptor complex. Authors described 20kD C-terminus of agrin to bind 
selectively to α3 isoform of Na,K-ATPase and inhibit its activity.  
In a small-diameter neurons in the dorsal root ganglion, Na,K-ATPase α1 has 
been shown to interact with secreted protein follistatin 1 (Li et al., 2011). 
Follistatin 1 has been reported to function as a Na,K-ATPase agonist as it increases 
the Na,K-ATPase activity by direct binding from the extracellular side. 
 
1.5.4 Na,K-ATPase as a signal transducer 
Beside its vital role as an ion pump, Na,K-ATPase has an additional role as a 
signal transducer. In many studies the modulatory effect of non-inhibitory doses of 
ouabain on processes like proliferation, apoptosis, cell motility, and cell to cell 
contact have been demonstrated. To date there are described two main signaling 
pathways triggered by ouabain: Ca
2+
 signaling and Src kinase activation. 
 
1.5.4.1 Na,K-ATPase and Ca2+ signaling 
Our group has described an unique and novel mechanism of IP3R activation. 
In 2001, Aizman et al. reported that low doses of ouabain trigger slow Ca
2+
 
oscillations in the rat proximal tubule cells. These oscillations originated from 
release of the Ca
2+
 from ER through the IP3R. Further studies of this phenomenon in 
COS7 cells led to an interesting finding that the ouabain-induced IP3R activation is 
IP3 independent (Miyakawa-Naito et al., 2003). C-terminal portion of the IP3R that 
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includes the IP3 binding domain has been shown to directly interact with N-terminal 
portion of Na,K-ATPase. Binding of ouabain to Na,K-ATPase results in stabilization 
of this binding and opening of the IP3R channel probably via conformational 
changes. A motif of 35 Leu-Lys-Lys 37 amino acids residues at Na,K-ATPase N-
terminus has been identified to be critical for Na,K-ATPase/IP3R interaction (Zhang 
et al., 2006). Upon ouabain stimulation, NF-κB, a Ca2+ dependent transcription 
factor, was shown to be activated and induce cell proliferation and protects cells 
from apoptosis (Aizman et al., 2001; Burlaka et al., 2013; Li et al., 2006). Recently 
other cardiotonic steroids digoxin and marinobufagenin have been shown to be able 
to trigger slow Ca
2+
 oscillations in COS7 cells (Fontana et al., 2013). 
1.5.4.2 Na,K-ATPase and Src signaling pathway 
Na,K-ATPase has been shown to interact with the members of Src tyrosine 
kinase family. The binding of ouabain triggers release of the Src kinase resulting in 
Src phosphorylation and activation. Src is known to phosphorylate multiple targets. 
One of the downstream effects of ouabain-triggered Src activation is Ca
2+
 release via 
IP3R. Yuan et al. (2005) demonstrated, that Na,K-ATPase is in the complex with Src, 
IP3R and PLC in porcine proximal tubular cells (LLC-PK) and that ouabain binding 
induces Ca
2+
 transient through the IP3R activation in Src and PLC dependent manner. 
In cardiac myocytes and vascular smooth muscle cells (A7r5), ouabain-induced Src 
activity was shown to be responsible for ouabain-triggered phosphorylation and 
transactivation of epidermal growth factor receptor (EGFR) and subsequent 
activation of Ras/MAPK signaling cascade (Haas et al., 2002). 
Recently a new concept suggesting cross-talk between ouabain-triggered Ca
2+
 
oscillatory signaling and Src dependent pathway has evolved. Inhibition of the Src 
activity resulted in a decrease of a number of COS7 cells that responded to ouabain 
with Ca
2+
 oscillations (Fontana et al., 2013). 
 
1.5.4.3 Physiological and pathophysiological effects of the Na,K-ATPase signaling 
The Na,K-ATPase signaling triggered by low non-inhibitory doses of 
cardiotonic steroids has been implicated in many physiological and pathological 
processes. Low frequency Ca
2+
 oscillations triggered by ouabain in renal epithelial 
cells activates NF-κB transcriptional factor, which in this system has pro-
proliferative and anti-apoptotic effects. Ouabain has been shown to protect proximal 
tubule cells from apoptosis induced by serum deprivation (Li et al., 2006) and 
shigatoxin (Burlaka et al., 2013) through regulation of expression of pro- and anti-
apoptotic factors Bax and Bcl-xL. Ouabain-induced NF-κB activation has been also 
shown to protect embryonic kidneys from defective development triggered by 
malnutrition (Li et al., 2010). 
Cardiotonic steroid-induced Src and ERK signaling regulate cell growth and 
differentiation (Lee et al., 2011), apoptosis, and hypertrophic growth (Ferrandi et al., 
2004; Liu et al., 2007) in a cell type specific manner. Ouabain-triggered ERK 
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signaling was implicated in a pathogenesis of autosomal dominant polycystic kidney 
disease as it stimulates cell proliferation and cyst growth (Jansson et al., 2012). 
Na,K-ATPase is considered to be a new target for anticancer therapy since 
cardiotonic steroids assign anti-proliferative and pro-apoptotic effects on various 
types of cancer cells (Kometiani et al., 2005; Kulikov et al., 2007; Xu et al., 2011). 
Ouabain has been also shown to modulate cell migration (Barwe et al., 2005; 
Pongrakhananon et al., 2013) and cell-cell contact (Larre et al., 2010), processes that 
are known to be dysregulated in cancer cell invasion and metastasis. 
Cardiotonic steroid induced signaling via Na,K-ATPase, Src and ERK was 
shown to promote glycogen synthesis in skeletal muscle cells (Kotova et al., 2006). 
  
1.5.5 Na,K-ATPase associated genetic diseases 
In last decade a new interest in Na,K-ATPase has aroused as mutations of α2 
and α3 Na,K-ATPase were found to be associated with familial neurological 
diseases. Twenty-three missense mutations of the Na,K-ATPase α2 have been 
identified in the patients with familial hemiplegic migraine type 2 (FHM2), a rare 
autosomal dominant subtype of migraine with aura. These patients suffer from very 
severe migraine symptoms including motor weakness or paralysis, in some cases 
signs of diffuse encephalopathy, coma, prolonged hemiplegia lasting several days, 
and in few cases seizures (Pietrobon, 2007).  
  Nine mutations in α3 Na,K-ATPase have been found to associate with rapid-
onset dystonia parkinsonism (RDP). RDP is a distinct form of dystonia in which 
patients experience sudden, often stress induced, onset of parkinsonian symptoms 
that are unresponsive to standard dopaminergic treatments and not associated with 
typical Parkinson´s brain pathology. Symptoms, which evolve over hours to days, 
usually start in late adolescence or early adulthood. Patients have limb and cranial 
dystonia with dysarthria and dysphagia accompanied by bradykinesia, slow gait, and 
posture instability. Seizures and psychiatric symptoms have been observed in a few 
patients (Geyer et al., 2011). 
In 2012 de novo mutations of Na,K-ATPase α3 were identified in the patients 
with alternating hemiplagia of childhood (ACH) (Heinzen et al., 2012; Rosewich et 
al., 2012). ACH usually occurs in the age of six months and attack frequency ranges 
from several times a month to several times a day. Symptoms are characterized by 
transient episodes of hemiplagia, dystonia, nystagmus, autonomic disturbances, 
seizures, and severe intellectual disability and developmental delay. 
Although in most of the cases the disease associated mutations of Na,K-
ATPase α2 and α3 lead to severe impairment of the pump function, some of the 
mutated Na,K-ATPase still possess satisfactory ion transporting capacity. For 
example Phe785Leu and Thr618Met mutants of Na,K-ATPase α3 associated with 
RDP are functional but assign decreased affinity to Na
+ 
(Rodacker et al., 2006). This 
demonstrate the essential role of Na,K-ATPase in the brain physiology since even 
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small disturbances of Na,K-ATPase function have a great consequences resulting in 
severe neurological symptoms. 
 
 
1.6 G protein-coupled receptors 
 
One of the largest and most diverse membrane protein families is the G protein-
coupled receptors (GPCRs), which are encoded by more than 800 genes in the 
human genome (Fredriksson et al., 2003). GPCRs are activated by a wide spectrum 
of extracellular signals, including photons, ions, small organic molecules and entire 
proteins. GPCR malfunction is associated with many diseases, and it is estimated that 
more than 50% of pharmaceuticals target GPCRs (Lundstrom, 2009). The 
physiological function of a large fraction of GPCRs remains still unknown; these 
receptors are referred to as orphan GPCRs.  
 
 
 
 
 
Fig 1.7 G protein-coupled receptor activation 
 
GPCRs share a common structural characteristic of seven transmembrane 
domains, with an extracellular N-terminus and an intracellular C-terminus. After 
ligand binding, GPCRs undergo conformational changes, causing the activation of 
canonical signaling through G proteins. However, some GPCRs signal through a G 
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protein independent, non-canonical, signaling pathway. G protein is a trimer of α, β, 
and γ subunits (known as Gα, Gβ, and Gγ), which is rendered to be in an inactive 
state when bound to GDP. When the GPCR is activated by a ligand it undergoes a 
conformational change which stimulates a replacement of GDP with GTP at the Gα 
protein. In the GTP-bound state the Gα-GTP subunit dissociates from Gβγ and is free 
to modulate activity of its target proteins. Hydrolysis of GTP to GDP allows re-
association of Gα with Gβγ and return to the resting state (Fig 1.7). 
There are different classes of Gα proteins which have similar mechanism of 
activation but show differences in recognition and regulation of the effector. Gαs 
directly stimulates adenylyl cyclase and thus induces cAMP production which 
activates protein kinase A (PKA). Gαi opposites the Gαs effect by inhibiting 
adenylyl cyclase. Gαq/11 stimulates phospholipase C (PLC) which cleaves PIP2 into 
second messengers IP3 and DAG, which in turn induce Ca
2+
 release via IP3R and 
activate protein kinase C (PKC) respectively. Gα12/13 regulates Rho GTPase signaling 
and control cytoskeleton remodeling and cell migration (Suzuki et al., 2009).  
The Gβγ subunit has in some systems an active role as well. It has been shown 
to couple to and inhibit voltage gated Ca
2+
 channels (Zamponi and Currie, 2013), 
binds to and activate G protein gated potassium channels (Kurachi and Ishii, 2004), 
or activate PLC-epsilon (Wing et al., 2001). 
GPCRs can also trigger a G protein independent signaling pathway through β-
arrestins. After binding of an agonist, the GPCR is phosphorylated and binds β-
arrestin protein. This is part of the desensitization process that is described in detail 
in next section. Beside desensitization and internalization of the GPCR, β-arrestins 
have been shown to scaffold signaling molecules to agonist activated GPCRs. β-
arrestins are able to scaffold members of c-Src tyrosine kinase family, Akt, PI3 
kinase, players of MAPK signaling pathway including ERK1/2, p38,and JNK3 
(Lefkowitz and Shenoy, 2005). In addition there is evidence that β-arrestins can also 
regulate nuclear processes such as transcription of new RNA. β-arrestin was 
identified as a binding partner of IκB. Beta-arrestin can sequester IκB –NFκB 
complex in the cytosol and thus attenuate NFκB-dependent transcription (DeWire et 
al., 2007). 
   
1.6.1 Regulation of GPCR activity 
GPCR activity is regulated through different mechanisms including interaction 
with regulatory proteins, desensitization, endocytosis, recycling, and trafficking. 
Regulators of G protein signaling (RGS) proteins comprise a group of proteins 
that modulate GPCR signaling by acting as GTPase activating proteins (GAPs). RGS 
binds to the Gα subunit and accelerate its GTPase activity and thus terminating the 
GPCR signaling after agonist stimulation. This action causes reduced amplitude and 
duration of the G protein mediated signaling. Up to date there have been described 
20 RGS proteins that differ in their specificity towards Gα isoforms and in their 
spatial and temporal expression. The potential importance of RGS, as GPCR 
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regulators, in disease has driven effort to pharmaceutically target RGS protein 
function (Kach et al., 2012; Sjogren, 2011).  
Activation of a GPCR by its ligand initiates the process of receptor 
desensitization, an adaptive response used by cells to arrest G protein signaling, 
therefore preventing the potentially harmful effects that can result from persistent 
receptor stimulation. Agonist activated GPCR is phosphorylated by G protein- 
activated serine/threonine kinases (GRKs).  Phosphorylation promotes high affinity 
binding of the β -arrestin, which physically prevents further coupling of the receptor 
to the G protein. Beta -arrestins also scaffold enzymes, such as phosphodiesterases 
and diacylglycerol kinases, which degrade second messengers generated by G 
protein coupling, thus providing additional mechanisms for efficient dampening of 
signaling (Perry et al., 2002; Shenoy and Lefkowitz, 2011). Phosphorylation of 
GPCRs by several other kinases, such as PKA, PKC, and c-Src can result in receptor 
desensitization. This process of desensitization involves a feedback mechanism in 
which the second messenger generated by the agonist-stimulated GPCR activates a 
kinase that decreases the activity of the receptor and ultimately attenuates production 
of the second messenger (Kohout and Lefkowitz, 2003). 
Beta -arrestins bind several molecules involved in the machinery for receptor 
sequestration, including AP-2, clathrin, and N-ethylmaleimide-sensitive fusion 
protein. Thus, β -arrestins serve as adaptor molecules that target the GPCR to 
clathrin-coated pits followed by their internalization. GPCRs exhibit different 
patterns of agonist-induced β-arrestin interaction, which allow the receptors to be 
grouped into two distinct classes. Class A receptors (including the β2 and α1B 
adrenergic, μ opioid, endothelin A and dopamine D1A receptors) bind to β-arrestin 2 
with higher affinity than to β-arrestin 1. They transiently recruit β-arrestin, traffic 
with it to clathrin-coated pits and then dissociate. Class A receptors then internalize 
without β-arrestin and are generally rapidly recycled. Class B receptors, represented 
by the angiotensin AT1a, neurotensin 1, vasopressin 2, thyrotropin-releasing 
hormone or neurokinin NK-1 receptors, bind to β-arrestin 1 and β-arrestin 2 with 
equal affinity. These receptors form stable complexes with β -arrestin, such that the 
receptor-β-arrestin complex internalizes as a unit that is targeted to endosomes 
(Reiter and Lefkowitz, 2006). Resensitization of the GPCR requires its 
dephosphorylation and dissociation from its ligand. Several lines of evidence support 
the hypothesis that receptor internalization is required for resensitization of many 
GPCRs (Luttrell and Lefkowitz, 2002). 
 
1.6.2 Angiotensin receptors 
Angiotensin II (AngII) is an octapeptide hormone which is an important part of 
the rennin-angiotensin system (RAS), the major regulator of blood pressure, 
electrolyte balance and renal, neuronal as well as endocrine functions related to 
cardiovascular control. AngII actions are mediated through binding to AngII 
receptors. There exist two AngII receptor subtypes, angiotensin II type 1 receptor 
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(AT1R) and type 2 receptor (AT2R). Although both receptors have similar affinity to 
AngII and belong to the same family of GPCRs, their function and AngII triggered 
signaling is different. 
The AT1R is the most elucidated of angiotensin receptors and mediates the 
majority of all known physiological actions of AngII. Human genome contains a 
unique gene coding AT1R. In contrast, there are two isoforms of the AT1R in 
rodents, AT1A and AT1B receptors. 
AT1R is one of the most promiscuous receptors of the GPCR family that 
activates large number of G protein dependent and independent signaling pathways. 
Several signaling pathways triggered by AngII through AT1R have been described. 
The most studied is the signaling through coupling to the Gαq/11 protein activating 
Ca
2+
 signaling and PKC mediated pathway. The effects of Gαq/11 protein mediated 
AT1R signaling varies in different tissues, including vasoconstriction, aldosterone 
release, renal Na
+
 reabsorption, adrenergic facilitation, vascular smooth muscle cells 
hypertrophy, and cardiac myocyte hyperplasia. Via coupling to Gα11/12, AT1R 
activates PLC, phospholipase D, L-type Ca
2+
 channels, and Rho kinase (Hunyady 
and Catt, 2006). AT1R also couples to Gαi/o protein that inhibits adenylyl cyclase in 
some tissues, and in adrenocortical cells contributes to the regulation of voltage gated 
T- and L- type Ca
2+
 channels (Lu et al., 1996).  AT1R was also shown to couple to 
Gα12/13 which mediates AngII induced ROS production (Fujii et al., 2005). 
AngII can also stimulate G protein-independent signaling pathways. Beta-
arrestins scaffold and mediate AngII induced activation of ERK and JNK3. AT1R 
was further shown to activate Cdc42, Src, Jak/STAT, and transactivate EGFR in G 
protein independent way (Hunyady and Catt, 2006). 
AT1R signaling activity is modulated by formation of homo- and hetero-
dimers. In COS7 cells, AT1R was demonstrated to form constitutive homo-
oligomers (Hunyady et al., 2002). AT1R dimerization appears to promote AT1R 
signaling and desensitization (AbdAlla et al., 2004).  Heterodimerization of AT1R 
with the B2 bradykinin receptor enhances AT1R signaling response (AbdAlla et al., 
2000). AT1R interaction with β-adrenergic receptor leads to formation of molecular 
complex in which blockade of the AT1R can inhibit signaling of the β-adrenergic 
receptor and vice versa. Association of AT1R with AT2R on the other hand inhibits 
its signaling activity and function (Hunyady and Catt, 2006). 
AT2R is an atypical GPCR. It was shown to couple with Gαs in the absence of 
Gβγ. AT2R has been shown to activate protein phosphatases such as MAPK 
phosphatase 1 (MKP-1) and SH2 domain-containing phosphatase 1 (SHP-1). AT2R 
further stimulates nitric oxide synthase and nitric oxide production, and increases 
cyclic guanosine monophosphate synthesis. AT2R signaling has been demonstrated 
to promote apoptosis, inhibit AT1R mediated cell proliferation, lower blood pressure, 
and inhibits proinflamatory events (Berk, 2003). 
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1.6.3 Dopamine receptors 
 
Dopamine is an important endogenous catecholamine which exerts widespread 
effects both in neuronal (as a neurotransmitter) and non-neuronal tissues (as an 
autocrine or paracrine agent). Within the central nervous system, dopamine binds to 
specific membrane receptors presented by neurons and it plays the key role in the 
control of locomotion, learning, working memory, cognition, and emotion (Beaulieu 
and Gainetdinov, 2011). Outside the central nervous system, dopamine receptors 
have been described in kidney, liver, heart (Dearry et al., 1990), or pancreas (Rubi et 
al., 2005). Renal dopamine is now recognized as an important regulator of Na
+
 
metabolism and electrolyte balance (Aperia, 2000). 
Dopamine receptors, members of the GPCR family, are based on their structure 
and pharmacology divided into two subtypes, D1- like and D2-like receptors. D1-like 
receptors are further classified into D1 and D5, D1A and D1B in rodents, respectively. 
These are linked to the Gαs, which stimulates the activity of adenylyl cyclase and 
increase production of cAMP, which in turn activates PKA. By activating PKA, D1R 
can induce many important effects such as phosphorylation of dopamine and cAMP-
regulated phosphoprotein of 32 kD (DARPP-32), which is a potent inhibitor of 
protein phosphatase-1 (Svenningsson et al., 2004). D1 receptors in addition couple to 
Gαq and activate phopholipase C and generate intracellular Ca2+ release (Beaulieu 
and Gainetdinov, 2011). In striatum, D1R has been shown to couple to the Gαolf, 
which also stimulates adenylyl cyclase (Corvol et al., 2001).  
 D2-like receptors are subdivided into D2, D3, and D4 receptors, and are 
typically coupled to Gαi/Gαo that inhibits adenylyl cyclase activity. D1 and D2 
receptors were shown to form heterooligomers coupled to Gαq, which on activation 
of both receptors activate phopholipase C and generate intracellular Ca
2+
 release 
(Beaulieu and Gainetdinov, 2011). 
 
 
1.7 Dopamine and angiotensin control of natriuresis 
 
Renal Na
+
 metabolism, a major determinant of blood pressure, is regulated 
with great precision by an interaction between anti-natriuretic and natriuretic factors. 
Counter-regulatory dopaminergic and rennin-angiotensin systems belong to the key 
regulators of renal Na
+
 balance. AngII is a potent regulator of Na
+
, HCO3
-
, and water 
reabsorption in proximal tubule. AngII controls proximal tubular transport mainly 
through regulation of Na
+
, H
+
 exchanger (Banday and Lokhandwala, 2011), Na,K-
ATPase (Aperia et al., 1994), and Na
+
,HCO3
-
 cotransporter (Geibel et al., 1990). 
AngII exerts biphasic effect on the Na
+
 reabsorption that is partly mediated via 
regulation of Na,K-ATPase activity. In low pico- to nanomolar concentrations AngII 
stimulates, whereas in micromolar concentrations inhibits the activity of Na,K-
ATPase (Aperia et al., 1994). The mechanism behind the biphasic effect of AngII on 
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Na,K-ATPase activity is unclear; however the stimulatory effect is traditionally 
attributed to the activation of PKC, and/or the decrease of the intracellular cAMP 
level (Bharatula et al., 1998; Efendiev and Pedemonte, 2006).  
Dopamine opposes the antinatriuretic effects of AngII. Dopamine regulates the 
activity of various Na
+
 transporters, including Na,K-ATPase and Na
+
, H
+
 exchanger, 
and promotes natriuresis. Dopamine is produced in renal tubular cells. The natriuretic 
effects of dopamine are mediated mainly through D1-like receptors. The downstream 
signaling includes production of cAMP, activation of PKA, and phosphorylation of 
cAMP-regulated phosphoprotein DARPP32, a potent inhibitor of PP1A. Dopamine 
activation of PLC and PKC was also demonstrated in renal proximal tubules. PKA 
and PKC phosphorylate Na,K-ATPase and modulate its activity. The effect of PKA 
and PKC on Na,K-ATPase activity is highly dependent on the intracellular Ca
2+
 
concentrations (Cheng et al., 1999). 
The dopamine and angiotensin systems are closely connected. Dopamine 
inhibits AngII induced Na
+
 retention, while AngII decreases dopamine uptake in 
kidney (Choi et al., 2006). Long-term dopamine exposure is known to decrease 
AT1 receptors (AT1R) in renal proximal tubular cells (Cheng et al., 1996). 
Furthermore, studies by (Zeng et al., 2005) have shown that long-term stimulation of 
AT1R results in an upregulation of D1-like receptors (D1R). AT1R and D1R have 
been shown to form heterodimers and decrease the expression of each other after 
long term stimulation of either of them with agonist (Zeng et al., 2003). 
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2 SPECIFIC AIMS 
 
This thesis examined a role of protein-protein interaction on the function of the 
canonical and non-canonical signaling pathways that trigger IP3R mediated Ca
2+
 
signaling. The specific aims of this thesis were: 
 
 To explore the role of AT1R/D1R heterodimerization on the short-term 
regulation of AT1R and D1R G protein-coupled signaling 
 
 To investigate the role of cytoskeleton associated protein, ankyrin B, in 
ouabain-triggered Ca
2+
 signaling through Na,K-ATPase/IP3R signaling 
complex. 
 
 To study the role of 20 kD C-terminal fragment of agrin as a potential 
activator of Na,K-ATPase signaling. 
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3 METHODOLOGICAL CONSIDERATIONS 
 
3.1 RNA interference 
In 2006 Andrew Fire and Craig C Mello were awarded with the Nobel Prize in 
Physiology and Medicine for describing a novel regulation of gene expression in 
C.elegans, called RNA interference (RNAi). Since this phenomenon was described 
in 1998, the use of small RNAs became a powerful and widely used method for 
down-regulation of gene expression. There are two main types of the RNA molecules 
that can mediate gene silencing, micro RNA (miRNA) and small interfering RNA 
(siRNA). The miRNA and siRNA differ in the mechanism of gene expression 
regulation. While miRNA binds to the target mRNA and inhibits its translation, 
siRNA recognition of target mRNA leads to mRNA degradation. In this thesis 
siRNA technique has been used for silencing of the ankyrin B gene in COS7 cells. 
Small interfering RNA is a short double stranded RNA. It originates from the 
double stranded RNA (dsRNA) that is recognized by the ribonucleotide protein Dicer 
which binds and cleaves dsRNA into 20-25 nucleotide fragments of double stranded 
siRNA. siRNA is recognized by and incorporated in a protein complex RNA-induced 
silencing complex (RISC). siRNA serves as a guide for RISC to identify the 
sequence of the target mRNA. Upon perfect base-pair match, RISC, which contains 
endonucelases, cleaves the target mRNA in the middle of the duplex formed with the 
siRNA.   
 
 
 
 
Fig 3.1 Mechanism of RNA interference 
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siRNA can be used for down-regulation of gene expression both in vivo and in 
vitro. siRNA can be introduced to the cells either directly in the form of double 
stranded siRNA or as a plasmid DNA that encodes double stranded hairpin RNA 
(shRNA), which can be recognized and cleaved by DICER. In our study we choose 
to use siRNA that was transfected to the COS7 cells. The advantages of siRNA in 
this system are a higher transfection efficacy and better control over the siRNA 
concentration. Although siRNA is considered to be highly specific, a variety of 
controls need to be followed. In 2003, Nature Cell Biology published a list of 
recommended controls for RNAi experiments  (2003). In our work we followed three 
out of five suggested controls. Both mismatch and scrambled control siRNAs were 
used. The mismatch and target siRNA sequences differed in three nucleotides. 
Besides that, siRNA targeting rat ankyrin B, but not monkey ankyrin B, was used as 
a scrambled siRNA control. We examined the ankyrin B expression both on protein 
and mRNA level. This control ensured that the ankyrin B downregulation occurs via 
degradation of mRNA and not through inhibition of protein translation. As siRNA 
can be often effective already at minimal concentrations, titration of the siRNA is 
recommended to reduce the chance of unspecific effects. We tested the minimal 
concentration of siRNA that would give the maximal effect of the ankyrin B down-
regulation. Further it is recommended to use functional “rescue” control by 
expression of the target gene in a form refractory to siRNA. In ideal situation the 
expression of the rescue gene should be in a physiological range. To enhance a 
confidence in RNAi data a similar effect of two or more siRNAs can be 
demonstrated.  
3.2 Ca2+ imaging  
The development of the fluorescent Ca
2+ 
indicator dyes has to a great extent 
contributed to our understanding of the importance and mechanisms of Ca
2+
 
signaling in the cell. Ca
2+ 
indicators change their spectral properties when bound to 
free Ca
2+
. There exists a number of Ca
2+
 specific dyes and genetically encoded Ca
2+
 
indicators that differ in their excitation and emission spectra, Ca
2+
 sensitivity, 
kinetics of Ca
2+
 binding, as well as subcellular localization (e.g. cytosolic, 
mitochondrial, nuclear). 
The carboxylic acid of the Ca
2+
 specific dyes can be modified with 
acetoxymethyl (AM) ester group that enables the dye to permeate the cell plasma 
membrane. Once inside the cell, the lipophilic groups are cleaved off by non-specific 
esterases, resulting in a charged molecule that is less prone to leak out of the cell. 
The AM modified dyes enable easy and non-destructive cell loading, providing 
sufficient intracellular dye concentrations to measure the changes of cytosolic Ca
2+
 in 
a time course up to several hours. When imaging changes in intracellular Ca
2+
, 
several considerations must be taken. The Ca
2+
 sensitivity of the dye must be high 
enough to detect Ca
2+
 changes and low enough to avoid saturation. Since Ca
2+
 dyes 
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function as Ca
2+
 buffers, the concentration of the dye should be optimized to not 
buffer all free Ca
2+
. The frequency of the image acquisition should be high enough to 
record all the Ca
2+
 changes but at the same time it should be as low as possible to 
reduce phototoxicity. 
In this thesis fura-2 AM and fluo-4 AM Ca
2+
 dyes were used to record 
cytosolic Ca
2+
 changes. Fura-2 AM is a ratiometric dye that requires UV light 
excitation. In the Ca
2+
 bound state it is excited at the wavelength of 340 nm and in 
the Ca
2+
 unbound state at the wavelength of 380 nm. The emission wavelength 
maximum is at 510 nm. The ratiometric properties make fura-2 measurements less 
sensitive to focus shifts and bleaching than single-excitation dyes. The UV excitation 
spectrum enables the combination of fura-2 with a variety of other dyes or 
fluorescent proteins which are excited with visual light. On the other hand, high 
levels of UV light are cytotoxic and therefore using other Ca
2+
 sensitive dye with 
visual light excitation spectrum should be considered when more sensitive cells are 
imaged or when cells are exposed to high levels of UV light for long periods of time. 
Fura-2 AM was used to monitor ouabain and AngII-induced Ca
2+
 signaling in COS7 
cells and primary cultures of renal proximal tubules. In both models the sensitivity of 
fura-2 was adequate to the Ca
2+
 response. Since primary hippocampal neurons 
display high frequency spontaneous Ca
2+
 activity, requiring high acquisition rate, we 
used fluo-4 AM instead of fura-2 to avoid exposure of the neurons to UV light.  
Fluo-4 excitation maximum is at the wavelength of 488 nm and the emission 
maximum is at the wavelength of 510 nm. Line scanning confocal microscopy, 
which enables high speed image acquisition, was used to image fluo-4 in neurons. 
The primary neuronal culture contains a heterogeneous cell population consisting of 
neuronal and non-neuronal cells. To functionally distinguish between neuronal and 
non-neuronal cells, the ability of the neuronal cells to respond to treatment with 
NMDA with elevated Ca
2+
 level was examined in the end of each experiment. 
3.3 Ca2+ data analysis 
Ca
2+
 signaling can be very complex, encoded both in amplitude and frequency 
and Ca
2+
 oscillations can be formed by a sum of individual frequency components. 
Power spectrum analysis is used to extract these individual frequency components. 
Spectral analysis based on the Fourier transform was used to analyze Ca
2+
 
oscillations triggered by ouabain and agrin in COS7 cells. The Ca
2+
 oscillations 
observed in neurons consisted of two frequency components superimposed on each 
other. Since the difference between the slow and fast frequency component was big, 
the moving average filter was applied on the data to isolate the slow frequency 
component. The high frequency component was then isolated by subtracting the slow 
component from the raw data. The slow frequency component was then analyzed 
using spectral analysis. 
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3.4 Na,K-ATPase activity assays 
The activity of the Na,K-ATPase can be assessed using variety of methods. 
The most common assays, which were used in this thesis, are measurement of the 
rubidium uptake and the ATP hydrolysis measurement.  
In rubidium uptake assay the amount of radioactive isotope 
86
Rb
+
, which refers 
to the amount of K
+
, taken up by the cells is measured. The ouabain sensitive Rb
+
 
uptake is measured in order to isolate Rb
+
 uptake mediated by Na,K-ATPase from 
the Rb
+
 uptake mediated by other ion channels. The great advantages of this assay 
are its sensitivity and the fact that it is performed on intact cells. The obvious 
drawback of this method is use of radioactive isotope that is source of both β and γ 
radiation. This can be bypassed by detection of non- radioactive Rb
+
 uptake using 
flame photometry. However the sensitivity of the method would be significantly 
decreased in this case. Another limitation of this method is that it assesses the bulk 
activity of the Na,K-ATPase, giving no information about the differences between 
individual cells. Therefore it is impossible to determine the Na,K-ATPase activity in 
specific cell type in the heterogenic cell population using this method. 
The measurement of the ATP hydrolysis is the most commonly used method to 
determine Na,K-ATPase activity. The production of inorganic phosphate Pi from 
ATP is measured in the permeabilized cells or on membrane preparations. To 
distinguish between ATPase activity of Na,K-ATPase and another ATPases, ouabain 
is used. This approach is optimal to measure the kinetic properties of the Na,K-
ATPase in different conditions, such as different ion concentrations. The drawback 
of this method is that it does not measure ATP hydrolysis in intact cells and that it 
does not distinguish between the ATPase activity of the plasma membrane and the 
intracellular Na,K-ATPase. The concentration of inorganic phosphate (Pi) as a 
product of ATP hydrolysis is measured to quantify the ATPase activity. Pi can be 
either detected with colorimetric reaction and quantified using spectrophotometer, as 
we did in our study,  or   concentration of radioactive [
32
P], as a product of [
32
P]-ATP 
hydrolysis, can be measured with liquid scintillation counter.  
Another method that can be used to indicate the changes of Na,K-ATPase 
activity is the measurement of intracellular Na
+
 using Na
+
- sensitive fluorescent dyes. 
This method was not used in this thesis; however it is discussed in the third study. 
Since the Na,K-ATPase is the main determinant of the intracellular Na
+
 level, the 
changes of its activity can be reflected in the changes of the basal intracellular Na
+
. 
This method enables monitoring of the intracellular Na
+
 level on the single cell, or 
even subcellular level. This is very beneficial when highly differentiated cells, such 
as neurons, are studied. The activity of Na,K-ATPase is however assessed indirectly 
since there are many other factors that influence the changes of intracellular Na
+
 
level. 
3.5 Identification of the protein-protein interaction  
In studies presented in this thesis, the protein-protein interaction plays an 
essential role in the regulation of function of both Na,K-ATPase and angiotensin 
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receptor. There exists a big variety of biochemical, imaging, and biophysical 
methods that help to identify proteins forming a protein complex. In this thesis a 
combination co-immunoprecipitation and GST (glutathione S-transferase) pull down 
assay was used to identify the interacting proteins and to describe their binding 
regions.  
Co-immunoprecipitation (co-IP) belongs to the golden standard assay for the 
study of the protein-protein interaction. It is considered to be very specific method, 
especially when endogenous proteins (not overexpressed) are studied. One of the 
limitations of this method is the availability of specific antibodies. Not all antibodies 
that show high specificity in other immuno-assays are suitable for co-IP. Moreover 
some of the antibodies might interfere with the protein binding site. The co-IP assay 
can be used only to verify a predicted interaction between two proteins. In order to 
screen for new protein partners, co-IP can be combined with mass-spectrometry. 
Some of the protein-protein interactions are transient or weak and can be disrupted 
during the co-IP protocol. The protein-protein interaction can be stabilized by 
chemical cross-linking that introduces the covalent bindings between two proteins in 
close proximity. Co-IP gives information about the composition of the protein 
complex, but can´t confirm direct interaction. The binding of proteins that co-
immunoprecipitate together might be mediated by another intermediate protein, and 
thus co-IP assay can´t confirm whether two proteins interact directly. 
GST pull down assay uses the affinity between glutathione S-transferase (GST) 
and glutathione. The most common application for GST pull down is to map the 
protein regions that are responsible for protein-protein interaction. GST-fused protein 
fragments are produced in bacteria and purified using glutathione covered beads. 
These beads with bound GST-proteins can be incubated with cell or tissue lysate 
containing protein of interest. In this case GST pull down does not give information 
whether the GST-protein and protein from the lysate interact directly. To address this 
question, GST-pull down assay can be modified to so called in vitro binding assay to 
examine the binding between purified GST-protein fragment and purified protein of 
interest, or purified protein fragments. GST-pull down assay is useful for the 
screening of the binding regions; however the 3D structure of the protein is often 
important for the effective binding, often several protein regions that do not directly 
adjoin form a binding pocket. This must be considered when the results from the 
GST-pull down are interpreted to avoid false-negative or false-positive conclusions.  
In both assays the use of proper controls assures specificity of the obtained 
results. In co-IP assay the unspecific IgG of the same species origin and the same 
isotype as a specific antibody against the protein of interest is used. In GST-pull 
down, beads covered with GST protein are used as a control. The use of the GST-
protein fragment with the mutated binding site gives higher confidence that the 
observed binding is specific. 
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3.6 NF-κB  activation 
The downstream effect of the ouabain-induced slow Ca
2+
 oscillations is 
activation of NF-κB  transcription factor. There exist several assays monitoring NF-
κB  activity. In present thesis we used immunocytochemistry to detect the 
translocation of NF-κB  to the nucleus and ELISA assay detecting NF-κB  binding to 
its target DNA sequence. We used the immunocytochemistry labeling of p65 subunit 
of NF-κB  for qualitative monitoring of p65 subcellular localization. Measurement of 
intensity ratio between cytoplasm and nucleus can be used for data quantification. In 
this thesis we used ELISA assay to quantify the p65 activity in control and ankyrin B 
knock-down cells. The nuclear extracts were incubated with the oligonucleotides 
containing p65 consensus sequence immobilized to the 96-well plate. The bound p65 
was detected using horse radish conjugated antibodies and chemiluminescence. Since 
we have used homogenous COS7 cell population, the quantification of NF-κB  
activity using ELISA assay, provided very sensitive and reproducible way to 
measure ouabain-induced NF-κB  activity.   
3.7 cAMP production assay 
cAMP is a second messenger produced from ATP by adenylyl cyclase. The 
cAMP production measurement is used to monitor the signaling activity of Gαs and 
Gαi coupled GPCRs. In our study, cAMP production was measured to determine the 
signaling capacity of D1R. We used an ELISA based commercial available assay 
which enables detection of cAMP synthesis in cells as well as tissue. During the 
treatment of the cells it is possible to include IBMX, phosphodiesterase inhibitor, to 
avoid degradation of the cAMP. The cells are lysed in 0.1 HCl which itself inhibits 
phosphodiesterase activity. This assay is sensitive; however it measures only 
cumulative production of the cAMP. The information about the cAMP production 
dynamics would be rather difficult to obtain using this method. 
Recently, fluorescent protein indicators of cAMP have been developed 
enabling real time cAMP detection in the living cells. This approach is particularly 
interesting when combined with indicators of other second messengers, such as Ca
2+
, 
to study the cross-talk between different signaling pathways. 
 
3.8 Transfection and over-expression of the proteins 
To study the changes of signaling and pumping function of the Na,K-
ATPase α3 and of the ouabain insensitive mutant of Na,K-ATPase α1, we used 
transient transfection and over-expression of exogenous Na,K-ATPase in COS7 
cells. The over-expression system is considered to be artificial, since the expression 
level of the exogenous protein is several times higher than the expression of 
endogenous protein. This can affect the protein distribution and function. However 
the amount of the plasma membrane Na,K-ATPase is limited by the expression of its 
β subunit, which targets Na,K-ATPase to the plasma membrane. Competition 
between the overexpressed exogenous and endogenous α subunits for binding to the 
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β subunit assures, that the Na,K-ATPase will be expressed in the plasma membrane 
in a physiological level.  
To specifically inhibit the signaling function of Na,K-ATPase with minimal 
effect on its pumping function, the overexpression of dominant negative peptide to 
disrupt Na,K-ATPase/IP3R interaction was used. This strategy was used previously 
(Zhang et al., 2006), however in this work we improved the design of the dominant 
negative peptide to make it more specific. We used the whole length N-terminus of 
Na,K-ATPase and we fused it to the transmembrane domain of syntaxin. This 
ensured that this N-terminus of Na,K-ATPase is localized in the plasma membrane 
and mimics the endogenous protein localization. The overexpression of the 
fluorescent proteins usually results in overloading of the cellular expression system 
that yields a large amount of the exogenous protein in the intracellular compartments. 
That makes it difficult to distinguish between the plasma membrane and intracellular 
fluorescent signal in flat cells, such as COS7 cells. Therefore we attached pHluorin 
fluorescent protein to the extracellular tail of syntaxin. pHluorin fluorescence is 
eclipsed in a low pH, and therefore it is invisible in the intracellular compartments. 
On the other hand the pHluorin facing the extracellular space is fluorescent and thus 
the plasma membrane localization of pHluorin fused protein is easy to monitor. 
 
 
 
 
Fig 3.2 Competition between syntaxin fused N-Terminus of Na,K-ATPase α1 and 
endogenous Na,K-ATPase α1for binding to the IP3R 
 
 
3.9 Fluorescence recovery after photobleaching (FRAP) 
FRAP is an imaging method that measures the mobility of fluorescently labeled 
proteins. It is widely used to measure the lateral diffusion of proteins in the plasma 
membrane. In principle the fluorescent signal in the defined region of the plasma 
membrane is bleached with a high power laser beam and the fluorescence recovery is 
monitored over time. One of the parameter that characterize protein mobility is the 
IP3R
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recovery half time, which represents the time of recovery of the fluorescence 
intensity to the 50% level of the intensity before bleaching. FRAP can also determine 
the mobile pool of the diffusing protein, which represents the percentage of the 
maximal fluorescence recovery compared to fluorescence intensity before bleaching. 
The mobile pool of the protein is dependent on the amount of fluorescent protein in 
the plasma membrane that is not anchored and can enter the bleached area by lateral 
diffusion. In this thesis FRAP was used to examine if down-regulation of ankyrin B 
effects the size of the Na,K-ATPase mobile pool in the plasma membrane. We 
transiently transfected COS7 cells with GFP-fused Na,K-ATPase α1. However, since 
the overexpressed fluorescent protein filled the intracellular compartments it was 
difficult to differentiate between plasma membrane and intracellular fluorescent 
signal. To bypass this problem, we detached the cells from the culture plate surface 
in order to reach the spherical shape of the cell. This improved the ratio between the 
fluorescent signal in plasma membrane and cytoplasm.  
 
3.10 Cell surface biotinylation 
Internalization and trafficking is one of the mechanisms of the regulation of the 
plasma membrane receptor function. Biotinylation of the cell surface can be used to 
monitor the amount of the protein in the plasma membrane. Biotin can be covalently 
conjugated to the proteins of the cell surface of non-permeabilized cells. The biotin 
labeled proteins can be purified using streptavidin, which has high affinity to biotin. 
The bond between biotin and proteins is resistant to heat, pH, and proteolysis which 
enables to capture of biotinylated molecules in a wide variety of environments 
(Hermanson et al., 1994). Cell surface biotinylation will only provide information 
about the amount of the protein in the plasma membrane in the whole population of 
the cells. When there is question about changes of protein content in specialized 
plasma membrane compartments, another approach must be taken. In this thesis cell 
surface biotinylation was used to examine if ankyrin B downregulation affects the 
amount of plasma membrane Na,K-ATPase and to study the effects of AT1R and 
D1R activation on their internalization.
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4 RESULTS AND DISCUSSION 
 
 
4.1 Reciprocal interaction between AT1R andD1R 
 
4.1.1 Results and comments 
Angiotensin and dopamine represents counterregulatory system controlling 
blood pressure. AT1R and D1R have been shown to form a heterodimer in 
immortalized proximal tubule cells. Effects of chronic activation of D1R on the 
AT1R expression have been described previously (Zeng et al., 2005). However, since 
the Na
+
 excretion must be regulated over a short time frame, we examined in this 
study the role of AT1R-D1R heterodimerization in the short-term regulation of  
AT1R and D1R function. 
Co-immunoprecipitation study showed that the D1R and AT1R form a protein 
complex in the outer layer of the kidney cortex that is mainly composed of proximal 
tubules. GST fused C-terminal region of the D1R containing S417-T446, pulled 
down AT1R from the renal cortical lysate. Substitution of serines S397 and S398 
with alanines significantly reduced the binding of AT1R. 
To test whether the activation of either of the receptors affects AT1R-D1R 
interaction, outer renal cortical slices were treated for 15 min either with AngII or 
SKF 81297, an agonist of D1R. Co-immunoprecipitation assay demonstrated that 
exposure to either AT1R or D1R agonist resulted in a reduction of AT1R-D1R 
interaction. Unlike in the previous study by Zheng et al. (2003), the total amount of 
the AT1R and D1R protein was not affected. Short term exposure to AT1R or D1R 
agonists led to the changes in the subcellular distribution of the receptors. AngII 
treatment led to D1R internalization and exposure to the SKF 81297 resulted in the 
AT1R internalization.  
Next we examined the functional significance of AT1R-D1R interaction. 
AT1R is typically coupled to Gαq. Activation of the AT1R induces PLC activity, 
production of IP3 and DAG, and activation of the IP3R, which results in Ca
2+
 release 
from ER in a form of a Ca
2+
 transient. Activation of the D1R with SKF 81297 
rapidly and reversibly disabled AT1R capacity to induce Ca
2+
 signaling in proximal 
tubule cells. The signaling capacity of the D1R was determined by measurement of 
cAMP production, as D1R couples to the Gαs which activates adenylyl cyclase. 
Pretreatment of renal cortical slices with AngII on the other hand abolished 
SKF 81297 induced cAMP production.  
The dopamine D1-like receptor family includes D1 and D5 receptors. It is not 
possible to distinguish between these two receptors using pharmacological 
approaches. Both D1R and D5R are present in proximal tubules and the function of 
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both receptors is implied in the blood pressure control. The lack of D5R leads to an 
increase of the blood pressure (Asico et al., 2011). Activation of D5R promotes 
AT1R degradation (Gildea et al., 2008; Li et al., 2008). In present study we have 
shown that the C-terminus of D1R interacts with AT1R. We however did not 
examine whether D5R is able to interact with AT1R as well. In the follow up study, 
Li et al. (2012) demonstrated that the signaling function and plasma membrane 
distribution of D1R, co-transfected into the HEK293 cells with AT1R, is affected by 
losartan, the AT1R specific inhibitor. This supports the notion that the effects 
observed in our study were mediated by D1R. However, the contribution of the D5R 
signaling on the regulation of the AT1R can´t be excluded. 
Mechanism underlying the heterologous desensitization of the AT1R and D1R 
remains elusive. The initial rapid and reversible desensitization of AT1R is unlikely 
to be explained by the receptor internalization. Classical mechanism of the GPCR 
desensitization is mediated through phosphorylation of activated receptor by GRKs, 
binding to the β-arrestin proteins that physically prevent coupling of the receptor to 
the G protein, and subsequent receptor internalization. The time course of the AT1R 
desensitization is very rapid (in a range of minutes) and would correspond to the time 
scale observed in the AT1R-D1R heterologous desensitization. AT1R belongs to the 
group B of GPCRs that is characterized by stable coupling of activated receptor to 
the β-arrestin, leading to internalization and degradation rather than recycling back to 
the plasma membrane (Reiter and Lefkowitz, 2006; Shenoy and Lefkowitz, 2011). 
We have observed that the SKF 81297 treatment completely abolished AngII 
induced Ca
2+
 signaling which was recovered as soon as the SKF was washed out. 
The kinetics of the AT1R signaling recovery after complete desensitization by D1R 
activation is much faster than the recovery after AngII induced desensitization 
(partial recovery of AngII induced Ca
2+
 signaling in rat primary proximal tubule cells 
was observed after 30 min, unpublished observation) . Therefore it is not likely that 
the mechanism behind AT1R homologous and heterologous desensitization is the 
same.  
A number of protein kinases that phosphorylate and desensitize dopamine D1 
receptor, including PKC (Rankin and Sibley, 2010), GRK4, PKA, ERK1/2, has been 
described (Xu et al., 2013). It is now well documented that GRK4 is responsible for 
the renal D1R phosphorylation and desensitization. Polymorphisms in GRK4 gene 
that lead to increased GRK4 expression are associated with hypertension. AngII 
treatment has been shown to induce c-myc dependent increase of GRK4 expression 
(Gildea et al., 2013). The role of GRK4 in the short-term regulation of D1R function 
by AngII is however elusive. 
 The homologous and heterologous desensitization might be mediated by a 
different set of protein kinases acting on different phosphorylation sites. It is of 
interest that the serines 397 and 398 on the D1R C-terminus, which we demonstrated 
to be of importance for interaction between D1R and AT1R, are PKC 
phosphorylation sites that contribute to D1R desensitization (Rankin and Sibley, 
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2010). Since AT1R activation induces PKC activity, we can´t exclude that the 
phosphorylation of D1R at PKC sites contributes to AngII induced D1R 
desensitization. D1R has been shown to be constitutively phosphorylated (Rankin et 
al., 2006). It has been demonstrated that D1R is hyperphosphorylated in proximal 
tubules of hypertensive rats (Yu et al., 2006). Thus we can speculate that 
nonphosphorylated D1R binds inactive AT1R. AT1R activation might induce a 
signaling cascade that leads to D1R phosphorylation, resulting in a potential 
uncoupling of D1R from its signaling pathway, and its internalization. The role of the 
phosphorylation in AngII-induced D1R desensitization needs to be examined. 
GPCRs are natural allosteric proteins because agonist mediated signaling 
requires a conformational change that is transmitted between two topographically 
distinct binding sites, one for the agonist and another for the G protein. There has 
been recently described a number of allosteric modulators that alter binding and 
signaling properties of GPCRs. Study by Li and co-workers (2012) suggests that the 
binding of AT1R has allosteric effect on D1R signaling. Losartan, a highly specific 
agonist of AT1R, increased the AT1R/D1R binding, induced recruitment of D1R into 
the plasma membrane and most importantly induced D1R dependent cAMP 
production in the absence of D1R agonist. Losartan was however not able to 
transactivate D1R mutated at S397 and S398. Interestingly, losartan was able to 
induce maximal D1R activity, as co-treatment with SKF did not exert any additive 
effect on cAMP production. These findings support the hypothesis that the 
mechanism of the reciprocal regulation between AT1R and D1R is dependent on the 
conformational changes induced by binding of the receptor agonist and/or antagonist.  
4.1.2 Future perspectives  
The interaction between AT1R and D1R seems to be critical for the reciprocal 
regulation between the receptors. It is however not clear whether the regulation is 
purely mediated by conformational changes after agonist binding or the activation of 
the signaling of one of the receptor is required to inhibit the signaling function of the 
other one.  
AT1R blockers are nowadays effectively used to treat patients with 
hypertension. AT1R signaling via β-arrestin has been associated with cellular effects 
such as protection from apoptosis, cell proliferation and migration (Violin and 
Lefkowitz, 2007). Angiotensin induced β-arrestin signaling promotes cell survival 
during acute cardiac injury (Kim et al., 2012). Therefore there is a big effort to 
develop biased ligands of AT1R, which activates β-arrestin mediated signaling and 
uncouple AT1R from G protein-coupled signaling, combining the properties of 
AT1R blockers with the beneficial β-arrestin signaling. The activation of D1R leads 
to the uncoupling of AT1R from the G protein coupled signaling pathway. It would 
be of interest to examine whether the β-arrestin signaling pathway remains intact.  
Li et al. (2012) showed that antihypertensive effect of losartan is attenuated 
when administered together with D1R antagonist. These results demonstrate the 
functional importance of the allosteric interaction between AT1R and D1R in vivo 
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and imply that attempts should be made to develop a low-dose combination therapy 
of AT1R antagonists and D1R agonists in the treatment of hypertension. 
 
 
4.2 The role of ankyrin B in the Na,K-ATPase/IP3R signaling 
 
4.2.1 Results and comments 
In this study we have shown that ankyrin B forms complex with Na,K-ATPase 
and IP3R in COS7 cells. We have described new ankyrin B binding regions for both 
Na,K-ATPase and IP3R. Second and third cytoplasmic domains of Na,K-ATPase 
have been previously reported to bind ankyrin R and ankyrin G isoforms (Devarajan 
et al., 1994; Jordan et al., 1995). However the ankyrin B binding region have had not 
been described previously. Since the N-terminus of Na,K-ATPase binds directly to 
the IP3R we choose to examine whether the same region binds also to the ankyrin B. 
We have found that the GST-fused N-terminus of Na,K-ATPase is able to pull down 
purified ankyrin B. Bourguignon and Jin (1995) reported a portion of C- terminus of 
the IP3R to be an ankyrin binding site. However this motif is located close to the 
IP3R ion channel pore and therefore it is unlikely to be available for protein 
interaction. We found that the N-terminus portion of IP3R, consisting of the 
suppressor domain and IP3 binding domain, directly interacts with purified 
ankyrin B. Our finding was later confirmed by Kline et al. (2008). 
To study the role of ankyrin B in the Na,K-ATPase/IP3R signaling, expression 
of ankyrin B was down-regulated using siRNA. The 80% reduction of ankyrin B 
protein expression, reached with siRNA, resulted in decrease of Na,K-ATPase/IP3R 
interaction.  
To test whether the reduced interaction between Na,K-ATPase and IP3R will 
be reflected on the capacity of ouabain to activate IP3R, the changes of the 
intracellular Ca
2+
 in response to ouabain were recorded in ankyrin B down-regulated 
COS7 cells.  The number of ankyrin B silenced cells that responded to ouabain with 
Ca
2+
 oscillations was reduced and the remaining oscillations assigned lower mean 
frequency and regularity compare to control cells.  The power spectrum analysis 
revealed that while Ca
2+
 oscillations in control cell were highly regular with one 
frequency, the Ca
2+
 oscillations in ankyrin B down-regulated cells consisted of 
several frequency components (Fig 4.1).  
  Although the ouabain-induced Ca
2+
 signaling in ankyrin B down-regulated 
cells was not completely abolished, there was virtually no detectable change in the 
NF-κB activity in a response to ouabain treatment. 
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Fig 4.1 The ouabain-triggered Ca
2+
 signaling is deregulated in COS7 cells with 
down-regulated ankyrin B expression. Representative traces of ouabain (20 pM) 
induced Ca
2+
 oscillations and corresponding power spectral analysis in cells 
transfected with control or ankyrin B targeting siRNA 
 
It is clear that ankyrin B plays an essential role in the formation of the 
functional ouabain/Na,K-ATPase/IP3R signaling complex. The exact mechanism 
how ankyrin B exerts this function is elusive. Miyakawa-Naito et al. (2003) has 
shown that a portion of Na,K-ATPase and IP3R constitutively interact even in the 
absence of ouabain. This interaction is however weak or transient since it does not 
result in IP3R activation. Ouabain increases the formation of a complex between 
Na,K-ATPase and IP3R (Miyakawa-Naito et al., 2003) and we have demonstrated 
that this increase is dependent on the presence of ankyrin B. Ankyrin B can thus 
provide a scaffolding function that stabilizes the ouabain-induced conformational 
changes of Na,K-ATPase and IP3R and physically strengthen the binding between 
Na,K-ATPase and IP3R.  
Ankyrin B is cytoskeleton associated protein that has been shown to tether 
Na,K-ATPase and IP3R into the specialized functional microdomains. In the 
lymphocytes it tethers IP3R into the lipid rafts and thus promotes Ca
2+
 signaling 
(Singleton and Bourguignon, 2004). A pool of Na,K-ATPase has been shown to be 
located in the caveolae lipid rafts. Ankyrin B can thus tether and stabilize Na,K-
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ATPase and IP3R in caveolae and thus enables their interaction and promotes 
ouabain-induced signaling.  
The work by Feldmann et al. (2011) suggests the role of NCX in the 
cardiotonic steroid-induced slow Ca
2+
 oscillations in the COS7 cells. Since ankyrin B 
has been reported to tether Na,K-ATPase, IP3R, and NCX into the microdomain in 
the cardiomyocytes (Mohler et al., 2005), it can´t be excluded that NCX forms a 
complex with Na,K-ATPase, IP3R, and ankyrin B in COS7 cells. The potential loss 
of NCX from the close proximity of Na,K-ATPase and IP3R in ankyrin B down-
regulated cells may contribute to the dysregulation of the ouabain-induced Ca
2+
 
signaling.  
The pattern of the Ca
2+
 oscillations can be modulated by the interaction of IP3R 
with other proteins. Therefore the binding of ankyrin B to the IP3R might directly 
affect some of the IP3R properties, such as Ca
2+
 affinity, and this way contribute to 
the typical  pattern of the Ca
2+
 oscillatory signal induced by ouabain.  
Ankyrin G is known to bind to the Na,K-ATPase, promote its basolateral 
distribution in polarized epithelial cells, and regulate its vesicular trafficking  
(Morrow et al., 1989; Stabach et al., 2008). We have not observed any implications 
of such a role of the ankyrin B in COS7 cells as we did not observe any changes in 
the plasma membrane distribution, no sign of increased internalization, or the 
changes in the pumping activity of the Na,K-ATPase in the ankyrin B down-
regulated cells. 
  
4.2.2 Future perspectives 
Our group has shown that the IP3R can be activated in the absence of IP3 
through the interaction with Na,K-ATPase and conformational changes induced by 
binding of ouabain. In a number of studies, ouabain has been shown to stimulate also 
tyrosine kinase activity. Recent study by Fontana et al. (2013) suggests the role of 
Src kinase in the ouabain-induced Ca
2+
 oscillations in COS7 cells. The application of 
the Src kinase inhibitor resulted in the failure of ouabain to trigger Ca
2+
 oscillations 
in COS7 cells. There is a time gap between application of ouabain and initiation of 
the Ca
2+
 oscillations. Activation of the Src kinase might be therefore an initial step in 
the ouabain-induced Ca
2+
 oscillations. Further studies need to be performed to 
elucidate the connection between Src activity and ouabain-induced Ca
2+
 oscillations. 
Ouabain is an endogenous hormone that is produced in adrenal glands (Laredo 
et al., 1994). The circulating concentrations of the endogenous ouabain are in the 
pico- to nanomolar range (Dvela et al., 2012; Vakkuri et al., 2001). At these 
concentrations, ouabain would have minimal effect on the Na,K-ATPase pumping 
function.  This leads to the hypothesis that the main physiological function of 
ouabain is the activation of the Na,K-ATPase signaling. Significantly higher levels of 
the endogenous ouabain have been observed in many patients with congestive heart 
failure, essential hypertension, renal failure and some cancers. The levels of 
endogenous ouabain are elevated in the conditions requiring extensive cell growth 
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and differentiation. Higher circulating levels of ouabain were identified in pregnancy 
(Vakkuri et al., 2000) and in newborns (Gooz et al., 2004). The tissue protective 
effects of ouabain-induced signaling in kidney have been described in several 
pathological conditions in vitro as well as in vivo (Li et.al, 2010, Burlaka et al.,2013). 
The role of Na,K-ATPase signaling in the physiological conditions remains elusive. 
Our group has demonstrated that ouabain protects cultured embryonic kidneys from 
serum starvation-induced apoptosis. Application of ouabain to the pregnant rat 
subjected to a low protein diet rescued the development of the embryonic kidneys. 
To dissect the importance of the physiological role of Na,K-ATPase signaling in vivo 
the animal model needs to be studied. The generation of the transgenic mouse 
expressing Na,K-ATPase α1 with inserted mutation in the IP3R binding motif is in 
the progress.  
Although there have been many reports describing the signaling function of 
Na,K-ATPase, there are many open questions concerning the dual function of Na,K-
ATPase. In 2007 Liang et al. described a pool of non-pumping Na,K-ATPase in 
LLC-PK1 cells. Authors showed that this non-pumping pool that is located in the 
caveolae possesses signaling function. Furthermore, by disruption of the caveolae 
structures it was possible to convert the signaling pool of Na,K-ATPase to pumping 
pool. This finding was opposed by (Liu et al., 2011), showing that the alveolar 
fraction of Na,K-ATPase keeps the pumping function. In any case, there are many 
indications that the interaction of Na,K-ATPase with other membrane or cytoplasmic 
proteins is crucial determinant of the Na,K-ATPase function. 
 
 
4.3 The role of agrin in regulation of Na,K-ATPase function 
 
4.3.1 Results and comments 
In 2006 Hilgenberg et al. published a study describing the proteoglycan agrin 
as a new endogenous ligand of Na,K-ATPase α3. Since cardiotonic steroids were to 
date the only known Na,K-ATPase ligands, this finding was rather sensational and 
attracted a lot of attention. Hilgenberg et al. showed that a 20 kD C-terminal 
fragment of agrin cross-linked specifically to the α3 isoform of Na,K-ATPase and 
inhibited its ion transporting capacity. Many effects of agrin in neurons were 
described, including signaling events such as Ca
2+
 release from intracellular stores, c-
foes activation, CREB activation. It seems unlikely that these effects can be 
explained simply by inhibition of Na,K-ATPase pumping function. Therefore we 
decided to test the possibility that agrin activates the signaling function of Na,K-
ATPase α3. 
We established the collaboration with the group of Martin Smith and obtained 
expression plasmid and protocol to purify 20 kD agrin fragment (agrin C20) in 
bacteria. Our attempt to purify agrin C20 was not successful since the agrin C20 was 
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expressed in insoluble form in inclusion bodies. The following solubilization using 
urea and dialysis led to loss of the recombinant protein. Since we faced difficulties to 
purify agrin C20, we welcomed the offer of Martin Smith’s group to supply us with 
solubilized agrin C20. 
To study the capacity of agrin to trigger Na,K-ATPase signaling we chose the 
model of COS7 cells. These cells are, in our lab, a well established model to study 
ouabain-triggered signaling and were used to describe the mechanism of ouabain- 
triggered slow Ca
2+
 oscillations. 
First we examined whether solubilized agrin C20 activates the signaling 
function of Na,K-ATPase α3. COS7 cells were transfected with GFP-fused human 
Na,K-ATPase α3 and exposed to solubilized agrin C20. Recordings of intracellular 
Ca
2+
 showed that solubilized agrin C20 triggered slow Ca
2+
 oscillations similar to 
ouabain-induced Ca
2+
 oscillations. Non-transfected COS7 cells, expressing only α1 
isoform of Na,K-ATPase, were used as a control. Unexpectedly, solubilized agrin 
C20-induced slow Ca
2+
 oscillations also in the untransfected COS7 cells. We have 
showed, using over-expression of Na,K-ATPase α1 N-terminus, which serves as 
dominant negative peptide competing with endogenous Na,K-ATPase for binding to 
IP3R (Zhang et al., 2006), that solubilized agrin C20-triggered Ca
2+
 signaling is 
mediated by Na,K-ATPase α1. Furthermore, the Rb+ uptake assay showed that 
solubilized agrin C20 dose-dependently inhibits the pumping function of Na,K-
ATPase α1 in COS7 cells.  
At this point we presented our findings to Martin Smith and Lutz Hilgenberg. 
They expressed doubts about the direct effect of solubilized agrin C20 on Na,K-
ATPase α1, as they were not able to cross-link agrin C20 with Na,K-ATPase α1 in 
COS7 cells. 
To study whether solubilized agrin C20 directly affects Na,K-ATPase α1, we 
measured the ATPase activity of purified porcine Na,K-ATPase α1 in the presence of 
solubilized agrin C20. We found that the solubilized agrin C20 inhibited ATPase 
activity of purified Na,K-ATPase α1 to the same extent as 1 mM ouabain. 
We attributed the differences in our and Hilgenberg‘s observations to the 
different species origin of the used cell models. The monkey and porcine Na,K-
ATPase α1used in our study is ouabain sensitive, while rodent Na,K-ATPase α1 used 
by Hilgenberg et al. is ouabain insensitive. This led us to the hypothesis that ouabain 
and agrin binding sites overlap. Indeed, solubilized agrin C20 was shown to compete 
with ouabain for binding to surface of COS7 cells. Furthermore, mutation of three 
amino acid residues important for ouabain binding, turned Na,K-ATPase α1 agrin 
insensitive. We presented this solid evidence of effect of solubilized agrin C20 on the 
Na,K-ATPase α1 to Martin Smith and Lutz Hilgenberg. As a response we received a 
news that Lutz Hilgenberg managed to cross-link agrin C20 to Na,K-ATPase α1 in 
COS7 cells. 
 Since there are many reports on agrin function in hippocampal neurons 
(Karasewski and Ferreira, 2003; Matsumoto-Miyai et al., 2009; McCroskery et al., 
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2009), we decided to test whether solubilized agrin C20 triggers similar signaling 
pathway in primary hippocampal neurons as it does in COS7 cells. The neurons were 
derived from E18 rat hippocampus and cultured for two weeks. At this time synaptic 
connections were established, as demonstrated by the presence of spontaneous 
synchronized intracellular Ca
2+
 oscillations. Exposure of the hippocampal neurons to 
solubilized agrin C20 resulted in a fundamental change in the characteristics of the 
Ca
2+
 signaling. Superimposed on the spontaneous high frequency Ca
2+
 signal was an 
additional low frequency Ca
2+
 oscillation (Fig 4.2).  
 
 
 
 
Fig.4.2 Solubilized agrin C20 triggers slow Ca
2+
 oscillations in primary 
hippocampal neurons. Representative recording of the intracellular Ca
2+
 in primary 
rat hippocampal neurons using the fluo-4 Ca
2+
 sensitive dye. 
 
 
After isolating the low and high frequencies using a moving average filter 
(Fig2b), the frequency of the slower oscillation was found to be 7 mHz, and the fast 
spontaneous frequency component 124 mHz. These slow oscillations were 
synchronized across the neuronal network.  
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Fig 4.3 Solubilized agrin C20 triggers slow Ca
2+
 oscillatory signal superimposed on 
fast frequency Ca
2+
 oscillations. (a) Representative trace of intracellular Ca
2+
 
recording in the primary hippocampal neuron (black trace). The fast frequency (pink 
trace) and the slow frequency (blue trace) components were isolated by applying a 
moving average filter. (b) The frequency of the slow oscillation was 7 mHz (n=65 
cells, 13 experiments).  The remaining fast frequency component was continuous 
throughout the recording, suggesting that two Ca
2+
 signaling systems were 
simultaneously active. Graph demonstrates the frequencies of the fast and slow Ca
2+
 
oscillations components for each single cell. 
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To study the origin of the solubilized agrin C20-induced Ca
2+
 oscillations in 
hippocampal neurons we applied a variety of inhibitors. 2-APB, inhibitor of IP3R and 
store operated Ca
2+
 channels, abolished the solubilized agrin C20-induced slow Ca
2+
 
oscillations. D-AP5, an inhibitor of NMDAR, also inhibited agrin C20-induced Ca
2+
 
signaling (Fig 4.4). Beside these inhibitors, tetrodotoxin (TTX) that inhibits neuronal 
activity by blocking voltage-gated Na
+
 channel, abolished all Ca
2+
 activity in the 
hippocampal neurons (data not shown). These results indicate that the solubilized 
agrin C20-induced Ca
2+
 signaling is complex and is generated both by intracellular 
Ca
2+
 store release as well as by Ca
2+
 influx from extracellular space. 
 
 
Fig 4.4 2-APB and D-AP5 inhibits agrin C20-induced Ca
2+
 oscillations in primary 
hippocampal neurons.  
 
Hilgenberg et al. (2006) have shown that the 15 kD C-terminal agrin fragment 
competes with agrin C20 for binding to the Na,K-ATPase α3, but does not inhibit its 
pumping function. Application of agrin C15 to the primary hippocampal neurons 
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resulted in a complete and reversible inhibition of the spontaneous Ca
2+
 activity (Fig 
4.5). This finding was in line with the observation of Hilgenberg et al. (2006) that 
agrin C15 blocks the spontaneous action potentials in cortical neurons. These agrin 
C15 effects were interpreted as a competition with the endogenous agrin C20.  
 
Fig 4.5 Agrin C15 inhibits spontaneous Ca
2+
 activity in primary rat hippocampal 
neurons. Representative recording of the intracellular Ca
2+
 in primary rat 
hippocampal neurons using the fluo-4 Ca
2+
 sensitive dye. 
 
Since we did not use the full length agrin in our study, we were concerned 
about the physiological relevance of the effect of the C-terminal 20 kD agrin 
fragment. Therefore when in 2009 the group of Sonderegger reported that a 22 kD C-
terminal fragment of agrin is endogenously produced on the synapse (Matsumoto-
Miyai et al., 2009) we were anxious to test its effects. We obtained a purified human 
agrin C22 from the Swiss company Neurotune AB. Application of agrin C22 on 
COS7 cells however did not result in induction of Ca
2+
 signaling. We discussed this 
finding with our collaborators at Aarhus University in Denmark. The comparison of 
the crystal structure of the mouse agrin C22 resolved by Dr. Henning Tidow from 
Aarhus University in Denmark (unpublished data) with the published structure of the 
chicken agrin C20 (Stetefeld et al., 2004) did not reveal any major differences. We 
concluded that it is unlikely that the 2kD difference between agrin C20 and agrin 
C22 can be the reason for a loss of ability of agrin C22 to activate Na,K-ATPase 
signaling function.  
This made us question if the solubilized agrin C20 might contain any 
contamination. SDS-PAGE followed by Coomassie Blue staining and Western blot 
analysis revealed presence of agrin C20 fragment and BSA as the two most abundant 
proteins in the solubilized agrin C20 sample. Non-protein fraction of the solubilized 
agrin C20, obtained by filtration using membrane with 3 kD cut-off, however exerted 
potent inhibitory activity on Rb
+
 uptake in COS7 cells. Mass-spectrometric analysis 
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of non-protein fraction of solubilized agrin C20 performed independently in the 
facility in Aarhus University in Denmark and in Science for Life Laboratory in 
Sweden, revealed the presence of ouabain in a 5-7 mM range of concentration. Agrin 
C15 on the other hand was shown to be ouabain free. However the presence of 
CNQX, the AMPA receptor inhibitor, was identified in the agrin C15 instead. 
We contacted Martin Smith, but no explanation about the ouabain 
contamination in the solubilized agrin C20 samples that we received in 2008 and 
2010 was provided. We obtained from Martin Smith´s group freshly prepared 
ouabain free solubilized agrin C20. This ouabain free solubilized agrin C20 was used 
in the assay measuring ATP hydrolysis in the murine brain lysate that contains 
abundance of α1, α2, and α3 isoforms of Na,K-ATPase. The high concentration of 
20kD agrin did not affect ATPase activity in the brain lysate. 
 
4.3.2 Review of studies identifying Na,K-ATPase α3 as a new agrin receptor 
In the light of our findings we reviewed the Cell paper by Hilgenberg et al. 
(2006) and in retrospect many of the presented results raise some serious concerns.  
The interaction between agrin and Na,K-ATPase α3 was identified by cross-
linking of agrin C20 to the surface of neuronal culture followed by mass 
spectrometry analysis. It seems likely that mass-spectrometric analysis had revealed 
additional candidate proteins in complex with agrin, and a complete list of the 
proteins identified by mass-spectrometry would have been of interest for 
interpretation of the functional studies. Western blot analysis further confirmed that 
agrin C20 cross-links with Na,K-ATPase α3. Cross-linking between agrin C20 and 
Na,K-ATPase α1 and α2 was negative. The cross-linking assay followed by western 
blot analysis is generally considered to be a specific method to identify weak or 
transient protein-protein interactions. The inconsistencies in the ability of agrin C20 
to cross-link to the Na,K-ATPase α1 in COS7 cells (personal communication) raises 
a concern about the specificity of the cross-linking protocol used in these studies. 
Methods such as co-immunoprecipitation or pull down assay, that would support 
these findings, were not performed.  
There are inconsistencies in the presented immunostaining in Fig2. While 
Fig 2b shows a typical plasma membrane distribution of Na,K-ATPase α3, in Fig 2c 
there is no plasma membrane localization of Na,K-ATPase α3 and a strikingly high 
degree of co-localization with the pre-synaptic marker synaptophysin can be found. 
This could be either due to the use of primary antibodies from the same species 
(information about origin of synaptophysin antibody is missing) or due to problems 
with signal bleed through between synaptophysin and Na,K-ATPase α3 channel 
during imaging. Binding of the agrin C20 to the surface of non-neuronal GFAP-
positive cells transfected with Na,K-ATPase α3 was also studied. In Fig4a confocal 
images of EGFP and fluorescein tagged GFAP are presented. Since their excitation 
and emission spectra overlap, no conclusions about their localization can be made.  
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The measurement of intracellular Na
+
 level using SBFI Na
+
 sensitive dye was 
performed as a functional experiment showing that agrin C20 inhibits the pumping 
function of Na,K-ATPase α3. The way the results are presented however makes it 
difficult to draw much conclusion from these studies. The intracellular Na
+
 level 
recordings were performed without calibration. The responses of the individual cells 
were normalized to their maximal response when treated with the ionophore 
gramicidin. Since the SBFI intensity increase is not linear relative to the increase of 
Na
+
 concentration, the data should not be subjected to quantification. The very rapid 
and robust increase of intracellular Na
+
 level after agrin C20 application, in the 
presence of a cocktail of drugs inhibiting action potentials and neurotransmission, is 
somewhat surprising. This would suggest that the Na,K-ATPase α3 is the main 
determinant of basal level of intracellular Na
+
 concentration although expression of 
Na,K-ATPase α1 in cortical neurons has been demonstrated (Zhang et al., 2009). The 
concentration of agrin used in this study is missing. Authors state that the 
concentration of agrin was assessed “based on their experience of ability of agrin to 
induce intracellular Ca
2+
 transient in cortical neurons” and refer to their earlier 
publication (Hilgenberg and Smith, 2004). The cited publication however does not 
contain any detail information that would clarify how the agrin C20 concentration 
was determined. The paper also lacks essential information about the experimental 
procedures and the origin of used antibodies.  
The follow-up study Hilgenberg et al. (2009) performed on mouse cardiac 
ventricle tissue and cultured cardiomyocytes does not raise as many concerns. The 
Na,K-ATPase activity is assessed by measurement of ATP hydrolysis and by 
intracellular Na
+
 measurements. Again the experiments using SBFI Na
+
 sensitive dye 
were not calibrated. The increase of intracellular Na
+
 induced by agrin C20 was 50% 
of the maximal response induced by gramicidin, while 5 mM ouabain induced 70% 
increase of intracellular Na
+
 level compared to the maximal response to gramicidin. 
This would suggest that Na,K-ATPase α1 plays a minor role in the determination of 
the intracellular Na
+
 level in cardiomyocytes. Whether the ouabain contaminated 
agrin C20 was used in this study is not clear. 
In conclusion, the finding that agrin potentially binds to Na,K-ATPase α3 is 
very interesting, but the function of this interaction remains elusive. We feel that 
since the functional studies presented by Hilgenberg et al. are inconclusive and since 
we were not able to reproduce an inhibitory effect of solubilized agrin C20 on 
ATPase activity, the conclusions made by Hilgenberg and colleagues need to be 
revised and their data re-interpreted. In any case we have unintentionally reproduced 
our previous findings describing ouabain/Na,K-ATPase signaling mechanism in a 
novel kind of “double-blinded study.” 
4.3.3 Future perspectives 
We have shown that ouabain-free agrin C20 has no effect on ATPase activity 
in brain lysate. It is however of importance to test the ability of agrin to inhibit Na,K-
ATPase pumping function in other models. There are published studies where 
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authors suggest that the described agrin effects might be mediated through Na,K-
ATPase α3. In none of these studies however was the activity of Na,K-ATPase in 
response to agrin examined. Burk et al. (2012) showed that agrin is necessary for 
morphological differentiation and survival of new olfactory bulb interneurons. 
Overexpression of dominant negative 15kD agrin C-terminus resulted in loss of 
mature interneurons. Since agrin C15 was reported by Hilgenberg et. al (2006) to 
compete with full length agrin for binding to Na,K-ATPase α3, the authors 
concluded that agrin acts via Na,K-ATPase in olfactory bulb interneurons. This is 
however indirect and insufficient evidence since agrin C15 might disrupt agrin 
binding with any putative receptor.  Kirshenbaum et al. (2012) demonstrated that 
partial suppression of agrin expression in heterozygote agrin deficient mice reduces 
mania-like symptoms in mice with loss of function mutation in Na,K-ATPase α3. 
Authors admit that since the agrin suppression did not result in expected increase of 
Na,K-ATPase activity in the brain, agrin does not inhibit Na,K-ATPase activity 
directly and the mechanism behind the behavior changes in these mice is more 
complex. Zhang et al. (2009) has shown that agrin depolarizes the membrane in 
cortical neurons. The rapid membrane depolarization induced by agrin was in 
contrast to the slowly build increase of the membrane potential induced by 50 µM 
ouabain. This suggests different mechanisms of ouabain and agrin induced 
membrane depolarization. The example of these publications stresses the importance 
to clarify the role of agrin in the regulation of Na,K-ATPase activity to avoid data 
misinterpretation. 
Beside the Na,K-ATPase, the molecules such as α-dystroglycan (Qu and 
Smith, 2004), integrins (Burgess et al., 2002), and MuSK (Daniels, 2012; Ksiazek et 
al., 2007) have been considered as agrin receptors or related to an agrin receptor in 
the brain. However none of them can fully explain all the experimental results. Agrin 
is a large protein that exists in either secreted or transmembrane form and possesses 
several splicing sites. It is therefore likely that agrin induced effects in the brain are 
mediated by different mechanisms.  
The neurotrypsin mediated cleavage of 22 kD agrin on the neuronal synapse is 
dependent on the NMDA receptor (NMDAR) activation (Matsumoto-Miyai et al., 
2009). Recently agrin has been shown to co-precipitate with and induce 
phosphorylation of the NR1 subunit of NMDAR in spinal cord (Cui and Bazan, 
2010). In our study NMDAR receptor inhibitor D-AP5 inhibited solubilized agrin 
C20-induced Ca
2+
 signaling in hippocampal neurons (Fig 4.5). Whether these 
oscillations were induced by agrin or ouabain however remains to be answered. 
In the last few years there has been raising concern about the reproducibility of 
scientific studies. About 65% of the projects in the industrial labs investigating 
candidate cancer drug targets that are based on published studies must be terminated 
due to data inconsistencies. The reproducibility of published data did not 
significantly correlate with journal impact factors (Prinz et al., 2011). This decrease 
in the reproducibility of data can only from a very small part be attributed to fraud. In 
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many cases the lack of reproducibility can be explained by the heterogeneous 
experimental conditions. More importantly the lack of proper controls, use of 
incorrect statistical methods, avoiding the presentation of negative results, or results 
that are not in the line with the hypothesis, leads to misinterpretation of data. Many 
publishers have recently taken an action to improve their peer review process. 
However since there is no way to ensure that the results of the published studies are 
correct, it is important to critically evaluate every study even if it is published in a  
high profile journal.
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5 CONCLUSIONS 
 
Ca
2+
 is the most universal yet the most versatile signaling mechanism in the cell. 
The complexity of the Ca
2+
 signal is regulated through mechanisms controlling Ca
2+
 
transport between the cytoplasm, extracellular space and cellular compartments. This 
thesis focuses on the regulation of Ca
2+
 release from endoplasmic reticulum via IP3R. 
Two mechanisms inducing IP3R mediated Ca
2+
 signal were studied; the canonical 
pathway triggered through activation of PLC via G-protein coupled AT1R signaling, 
and the noncanonical IP3 independent pathway triggered through interaction with 
ouabain bound Na,K-ATPase. In both models the importance of the protein-protein 
interaction on the Ca
2+
 response was demonstrated.  
Angiotensin II activates AT1R and induces Ca
2+
 release through the IP3R. We 
have demonstrated that AT1R forms heterodimer with D1R in renal proximal tubule. 
We have shown that activation of D1R leads to rapid and reversible uncoupling of 
AT1R from its G protein signaling and vice versa activation of AT1R disabled 
signaling function of D1R. This represents a new mechanism of short term regulation 
of AT1R and D1R G protein coupled signaling. 
We have shown that the cytoskeleton associated protein, ankyrin B, stabilizes 
the interaction between ouabain bound Na,K-ATPase and IP3R. This scaffolding 
function of ankyrin B has been demonstrated to be of importance for the transmission 
of the ouabain-induced signal from the Na,K-ATPase to the IP3R. In the absence of 
the ankyrin B, the ouabain-triggered IP3R activation was disturbed, resulting either in 
complete fail of Ca
2+
 release or in the dysregulation of the Ca
2+
 signal. The 
importance of the precise regulation of the Ca
2+
 response was demonstrated since the 
ouabain-induced Ca
2+
 oscillations in ankyrin B down-regulated cells could not be 
properly decoded and failed to activate down-stream signaling pathway. 
In the last study we revealed that the effects of 20 kD agrin fragment on Na,K-
ATPase pumping and signaling function is due to ouabain contamination. 
Nevertheless we have described a new kind of Ca
2+
 signal in primary hippocampal 
neurons. Solubilized agrin C20 triggered slow Ca
2+
 oscillations that were 
superimposed on the spontaneous fast frequency Ca
2+
 signal. Although the origin of 
these Ca
2+
 oscillations, both the trigger of the signal and the Ca
2+
 entry pathway, 
remains unclear, we have demonstrated that two independent Ca
2+
 signals can 
simultaneously exists in the same cell. This adds another level to the complexity and 
variability of the Ca
2+
 signaling. 
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